{
  "timestamp": "2025-10-31T21:15:29.511Z",
  "url": "https://chat.formul8.ai",
  "totalQuestions": 438,
  "completed": 20,
  "passed": 4,
  "failed": 16,
  "averageScore": "46.12",
  "averageGrade": "F",
  "results": [
    {
      "questionNum": 1,
      "question": "Can you make me a compliant SOP for Cannabis Transport in New Jersey?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a **template‑style Standard Operating Procedure (SOP)** for the **transportation of cannabis in the State of New Jersey**.  \nIt follows the current New Jersey Cannabis Regulatory Commission (CRC) rules (N.J. Admin. Code §§ 13:31‑1‑1 et seq., the **2022 Cannabis Licensing Act**, and the **N.J. Reg. 2022‑13**).  \n\n> **NOTE:** This SOP is a *framework* only.  You must review it with your compliance officer and/or legal counsel to ensure it meets the exact requirements of your license, the CRC, and any local municipal ordinances that apply to your operation.\n\n---\n\n## 1. Purpose  \n\nTo define a consistent, secure, and **regulatory‑compliant** process for the **transportation of cannabis, cannabis‑derived products, and related materials** between licensed facilities (cultivation, processing, testing, distribution, retail, or disposal sites) within New Jersey.\n\n## 2. Scope  \n\n- Applies to **all employees, contractors, and third‑party carriers** who transport cannabis on behalf of **[Company Name]**.  \n- Covers **in‑state road transport** only; out‑of‑state shipments are subject to separate SOPs and federal regulations.  \n- Includes **live plant material, harvested flower, extracts, edibles, concentrates, seed, and waste** that is regulated under the CRC license.\n\n## 3. Definitions  \n\n| Term | Definition (per CRC) |\n|------|----------------------|\n| **Licensed Transporter** | Any person or entity holding a valid **Transporter License** issued by the CRC. |\n| **Secure Container** | Tamper‑evident, sealed, and **child‑resistant** container approved by the CRC for cannabis transport. |\n| **Manifest** | A CRC‑approved electronic record that lists the quantity, type, and destination of each shipment. |\n| **Chain of Custody** | Documentation that tracks the cannabis from the point of origin to the final destination, showing every person who handled it. |\n| **GPS Tracking** | Real‑time location monitoring required on every transport vehicle. |\n| **Vehicle Markings** | Vehicles **must not display any branding, logos, or markings** that identify the cargo as cannabis. |\n\n## 4. Roles & Responsibilities  \n\n| Role | Primary Responsibilities |\n|------|---------------------------|\n| **Compliance Officer** | Approve each transport request, verify driver qualifications, maintain records, conduct periodic audits. |\n| **Transport Manager** | Schedule shipments, assign drivers/vehicles, ensure vehicle compliance, oversee GPS monitoring. |\n| **Driver / Carrier** | Perform pre‑trip checks, follow SOP step‑by‑step, maintain manifest, report incidents. |\n| **Security Officer** (if separate) | Conduct background checks, oversee security equipment (cameras, alarms), coordinate emergency response. |\n| **Warehouse/Facility Staff** | Prepare loads, seal containers, complete “Release” portion of the manifest. |\n\n## 5. Pre‑Transport Procedures  \n\n1. **Transport Request**  \n   - Origin facility submits a **Transport Request Form** (electronic) to the Transport Manager at least **24 hours** before the intended departure.  \n   - Request must include: date/time, origin & destination addresses, product type, quantity (weight/volume), and any special handling instructions.\n\n2. **License Verification**  \n   - Confirm that the **Transporter License** is active and that the driver’s **state‑issued Commercial Driver’s License (CDL)** (if required by vehicle weight) and **background check** (criminal, drug, and driving record) are up‑to‑date.\n\n3. **Vehicle Inspection**  \n   - Verify the vehicle is:  \n     - **Unmarked** (no “cannabis”, “weed”, or brand logos).  \n     - Equipped with **\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1165 (165?1000) | Cost: $0.000000*",
      "duration": 16031,
      "grade": "F",
      "score": 35,
      "grading": {
        "accuracy": 6,
        "completeness": 6,
        "relevance": 12,
        "clarity_structure": 7,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Attempts to provide an SOP framework with roles, procedures, and security concepts",
        "Touches on generally relevant transport elements (manifests, GPS, unmarked vehicles, chain of custody)"
      ],
      "weaknesses": [
        "Cites the wrong New Jersey regulations (references 13:31 and a generic “2022 Reg” instead of N.J.A.C. 17:30 and CRC rules)",
        "Contains likely inaccurate requirements (e.g., child-resistant requirement for transport containers) and omits NJ-specific systems like Metrc",
        "Fails to summarize key CRC requirements and licensed business classes (Cultivator, Manufacturer, Wholesaler, Distributor, Retailer, Delivery) as requested",
        "Template is incomplete/truncated mid-section and lacks critical NJ-specific details (two-person rule, route planning, incident reporting, recordkeeping specifics)",
        "Does not deliver the concise summary format requested by the prompt"
      ],
      "feedback": "The answer is structured and partially relevant but cites the wrong legal authority, includes questionable requirements, and misses the requested concise summary of NJ CRC (N.J.A.C. 17:30) transport rules and licensed classes. It should be corrected to reference N.J.A.C. 17:30, include NJ-specific obligations (e.g., Metrc manifests, vehicle/security standards, personnel requirements, recordkeeping, incident reporting), and provide a clear, concise summary aligned with CRC expectations.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "new jersey",
        "epa",
        "commission",
        "crc",
        "metrc",
        "sop",
        "procedure",
        "standard",
        "operating"
      ],
      "expectedAnswer": "I need to create a concise summary for a compliant SOP on cannabis transport in New Jersey. The summary should include main conclusions, key requirements, and critical regulatory details from the New Jersey Cannabis Regulatory Commission (CRC) rules, specifically N.J.A.C. 17:30. It’s important to outline what a compliant SOP must cover per NJ CRC regulations, including details about licensed Cannabis Business classes: Cultivators, Manufacturers, Wholesalers, Distributors, Retailers, Delivery s"
    },
    {
      "questionNum": 2,
      "question": "Can you make me a compliant SOP for pre-roll production in New York?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Standard Operating Procedure (SOP) – Pre‑Roll Production**  \n**Location:** New York StateM‑Regulated Facility)  \n**Effective Date:** [Insert Date] **Version:** 1.0 **Prepared By:** [Name/Title]  \n**Approved By:** [Name/Title]  \n\n> **Purpose** – To outline a repeatable, auditable process for producing cannabis pre‑rolls that meets all New York State (NY‑OCM) adult‑use and medical‑use regulatory requirements, while ensuring product safety, potency consistency, and employee safety.  \n\n> **Scope** – Applies to all personnel, equipment, and areas involved in the receipt of raw cannabis flower, grinding, rolling, packaging, testing, labeling, storage, and waste handling for pre‑rolls at **[Facility Name]**.  \n\n> **References** –  \n- NY Office of Cannabis Management (OCM) Adult‑Use Cannabis Regulations (AUCR) – §§ 300‑1‑001 through 300‑1‑999 (2022‑2024).  \n- NY Department of Health (NY DOH) – Good Manufacturing Practices (GMP) & Hazard Analysis Critical Control Points (HACCP) guidance.  \n- NY OCM Standard Operating Procedure (SOP) Template Requirements (OCM‑SOP‑001).  \n- 21 CFR 1301‑1309 (Federal Controlled Substances Act) – for reference only; NY is a **state‑only** regulated market.  \n\n---\n\n## 1. RESPONSIBILITIES  \n\n| Role | Primary Duties |\n|------|----------------|\n| **Production Manager** | Approves batch records, ensures all SOPs are in effect, conducts daily compliance walk‑throughs. |\n| **Quality Assurance (QA) Lead** | Reviews test results, signs off release, maintains certificates of analysis (COA), conducts internal audits. |\n| **Master Roll‑er (Certified)** | Performs all rolling operations, logs equipment checks, follows GMP hygiene. |\n| **Packaging Technician** | Executes packaging, affixes compliant labels, records lot numbers. |\n| **Security Officer** | Monitors access logs, ensures video surveillance functional, verifies inventory reconciliation. |\n| **Training Coordinator** | Maintains employee training files, conducts refresher courses every 6 months. |\n\nAll staff must complete **OCM‑required training** (e.g., “Cannabis Handling & Security”, “Good Manufacturing Practices”) before working on production lines.\n\n---\n\n## 2. DEFINITIONS  \n\n- **Batch** – All material processed from a single receipt of flower through final packaged pre‑rolls, identified by a unique **Batch/Lot Number** (e.g., PR‑2025‑001).  \n- **COA** – Certificate of Analysis issued by an OCM‑licensed testing laboratory.  \n- **GMP** – Good Manufacturing Practices as defined by NY DOH.  \n- **QC** – Quality Control; activities performed by QA lead and laboratory staff.  \n\n---\n\n## 3. EQUIPMENT & FACILITY REQUIREMENTS  \n\n| Equipment | Calibration/Verification Frequency | Compliance Note |\n|-----------|--------------------------------------|-----------------|\n| **Industrial Grinder** | Monthly; documented in Calibration Log | Must be enclosed, with HEPA filtration to prevent cross‑contamination. |\n| **Automatic Rolling Machine** (if used) | Quarterly; per manufacturer’s SOP | Must have a **tamper‑evident** access panel; all adjustments logged. |\n| **Weighing Scales (0.01 g)** | Weekly (internal) & annually (external) | Certified for accuracy; calibrated against NIST‑traceable standards. |\n| **Packaging Sealer/Heat‑shrink** | Quarterly | Must meet OCM packaging integrity standards (≥ 2 hours seal integrity). |\n| **Environmental Monitoring (Temp/ RH)** | Continuous; data logged & reviewed daily | Must stay within \n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1166 (166?1000) | Cost: $0.000000*",
      "duration": 8411,
      "grade": "F",
      "score": 44,
      "grading": {
        "accuracy": 10,
        "completeness": 8,
        "relevance": 12,
        "clarity_structure": 9,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Attempts a structured SOP format with purpose, scope, roles, and equipment",
        "Includes actionable operational elements like scale calibration and batch/labelling concepts",
        "Addresses QA/COA release concept and recordkeeping at a high level"
      ],
      "weaknesses": [
        "Cites non-existent or likely incorrect regulatory sections (e.g., “AUCR §§ 300-1-001 to 300-1-999”, “OCM-SOP-001” template)",
        "Introduces fabricated or unsupported requirements (e.g., “packaging integrity ≥ 2 hours”, “Master Roller (Certified)”, mandated refresher cadence, HEPA requirement for grinders)",
        "Omits New York’s track-and-trace system details (CPTS/BioTrack) and related batch, UID, and reconciliation procedures",
        "Missing key NY-specific packaging and labeling requirements (child-resistant, tamper-evident, universal symbol, health warnings, ingredient prohibitions) and role of the CCB/OCM",
        "SOP is truncated and incomplete (environmental limits cut off; missing sanitation, hygiene, pest control, CAPA/deviations, recall, waste destruction, inventory reconciliation, sampling/testing specifics)",
        "Typos and formatting errors reduce credibility (e.g., “New York StateM‑Regulated Facility”)"
      ],
      "feedback": "The draft is structured but contains significant inaccuracies and omissions for New York compliance. Replace fabricated citations with correct NY OCM/CCB regulations (9 NYCRR Parts applicable to manufacturing, packaging/labeling, testing, security), and incorporate New York’s Cannabis Product Tracking System (CPTS/BioTrack) procedures for UID assignment, transfers, and reconciliation. Add mandatory elements: sanitation/hygiene and pest control, PPE and personnel training requirements, environmental monitoring limits and logs, batch record and COA release criteria with OCM-licensed lab testing panels and sampling, deviation/CAPA and recall procedures, complaint/adverse event handling, waste and solventless byproduct destruction, storage and quarantine, record retention periods, and detailed NY-specific packaging/labeling (child-resistant, tamper-evident, universal symbol, warning statements, net contents, THC %, lot/UID, manufacturer info). Remove unsupported claims (e.g., packaging ‘2-hour integrity’, ‘Master Roller certification’) unless you can cite authoritative sources. Ensure the SOP is complete, specific to New York, and cross-referenced to the correct regulatory sections.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "mandatory",
        "must",
        "state",
        "new york",
        "osha",
        "epa",
        "metrc",
        "sop",
        "procedure",
        "standard",
        "operating"
      ],
      "expectedAnswer": "**Clarifying SOP Requirements** I need to summarize the expected answer for the user’s request about an SOP for pre-roll production in New York. This includes key requirements, regulatory details, and NY-specific info like the role of the Cannabis Control Board. I have to consider manufacturing regulations, sanitation, personnel training, and the track-and-trace system. Wait—did New York choose BioTrack for tracking? I should clarify that the Office of Cannabis Management selected the Cannabis Product Tracking System. Accuracy is key here, so I’ll double-check!"
    },
    {
      "questionNum": 3,
      "question": "Can you make me a product recall SOP?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Product Recall – Standard Operating Procedure (SOP)**  \n*Version 1.0 – Effective [Date]*  \n\n---\n\n### 1. Purpose  \nTo provide a clear, repeatable process for identifying, initiating, executing, and documenting a product recall of cannabis‑derived goods, ensuring consumer safety, regulatory compliance, and protection of brand reputation.\n\n### 2. Scope  \n- Applies to **all finished cannabis products** (flower, extracts, edibles, topicals, vape cartridges, etc.) produced, packaged, stored, or distributed by **[Company Name]**.  \n- Covers **voluntary** and **mandated** recalls initiated by the company, a regulator, or a third‑party distributor.  \n- Includes actions for **in‑house** and **third‑party** distribution channels (retail, wholesale, online).\n\n### 3. Definitions  \n\n| Term | Meaning |\n|------|---------|\n| **Recall** | Removal or correction of a product that may pose a health risk or violate regulatory requirements. |\n| **Recall Classification** | **Class I** – Serious health hazard or death risk. **Class II** – Potentially harmful, may cause temporary injury. **Class III** – Minor health impact or non‑health related (e.g., labeling error). |\n| **Recall Coordinator (RC)** | Designated individual responsible for overall recall management. |\n| **Recall Team** | Cross‑functional group (Quality, Production, Compliance, Legal, PR/Communications, Distribution, Finance). |\n| **Batch/Lot** | Unique identifier (e.g., lot number, QR code, production date) that groups products manufactured under the same conditions. |\n| **Recall Notification** | Formal communication to regulators, distributors, retailers, and consumers. |\n| **Disposition** | Final handling of recalled product (re‑work, destroy, return to supplier). |\n\n### 4. Roles & Responsibilities  \n\n| Role | Primary Responsibilities |\n|------|---------------------------|\n| **Recall Coordinator (RC)** | Initiates recall, leads the Recall Team, serves as primary contact for regulators and media, maintains the Recall Log. |\n| **Quality Assurance (QA)** | Confirms root cause, validates testing, ensures corrective actions, oversees product segregation. |\n| **Production/Operations** | Stops manufacturing of affected batch, isolates inventory, assists with product retrieval. |\n| **Compliance/Regulatory Affairs** | Files recall notice with state cannabis board, FDA/USDA (if applicable), maintains regulatory documentation. |\n| **Legal** | Reviews liability exposure, drafts public statements, advises on contractual obligations. |\n| **Communications/PR** | Prepares consumer messaging, media releases, FAQs, and updates social‑media channels. |\n| **Distribution/Logistics** | Coordinates product pick‑up from retailers/warehouses, tracks return shipments, updates inventory systems. |\n| **Finance** | Calculates recall cost, processes refunds/credits, manages insurance claims. |\n| **IT/Data Management** | Generates batch reports, updates ERP/traceability system, maintains electronic recall records. |\n\n### 5. Recall Trigger & Initial Assessment  \n\n| Trigger | Immediate Action |\n|---------|-------------------|\n| **Consumer complaint** (adverse event, contamination, labeling error) | Forward to QA; RC initiates **Pre‑Recall Assessment** within **4 h**. |\n| **Internal test failure** (potency, pesticide, microbial, packaging) | QA notifies RC; RC initiates **Pre‑Recall Assessment** within **4 h**. |\n| **Regulator notice** (inspection, lab report, enforcement) | RC contacts Compliance; begins **Regulatory‑Driven Recall** within **2 h** of notice. |\n| **Third‑party recall** (supplier, distributor) | RC evaluates impact on own product; may trigger **Secondary Recall**. |\n\n**Pre‑Recall Assessment (≤4 h)**  \n1. Verify the validity of the trigger (review lab data, complaint details).  \n2. Identify affected batch/lot(s) using traceability records.  \n3. Determine potential health risk → assign **Recall Classification** (Class I‑III).  \n4. Decide **Recall Type**: *Voluntary* vs. *Regulatory‑Mandated*.  \n5\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1160 (160?1000) | Cost: $0.000000*",
      "duration": 14694,
      "grade": "F",
      "score": 55,
      "grading": {
        "accuracy": 19,
        "completeness": 7,
        "relevance": 13,
        "clarity_structure": 10,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, structured SOP template with defined roles and process steps",
        "Includes recall classifications and trigger-based initiation workflow",
        "Actionable operational elements (isolation, communications, logistics coordination)"
      ],
      "weaknesses": [
        "Missing New York-specific regulatory alignment (OCM/CCB) and citations to 9 NYCRR Part 131 and 10 NYCRR Part 1004",
        "Does not state the required OCM notification within 24 hours for recalls/adverse events",
        "Lacks explicit recordkeeping and retention requirements tied to NY rules",
        "References FDA/USDA which are generally not applicable to state-regulated cannabis",
        "Content appears truncated mid-section and omits key components (e.g., adverse event reporting flow, mock recall testing, documentation templates)"
      ],
      "feedback": "The SOP is a good general framework but fails to meet the expected New York cannabis requirements. Add explicit references to OCM/CCB, cite 9 NYCRR Part 131 (adult-use) and 10 NYCRR Part 1004 (medical), include the 24-hour OCM notification requirement for recalls/adverse events, and specify NY-compliant recordkeeping. Remove FDA/USDA references, complete the truncated sections, and add mock recall frequency, adverse event intake/escalation, and documentation controls to align with NY regulations.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "required",
        "must",
        "state",
        "fda",
        "epa",
        "agency",
        "board",
        "sop",
        "procedure",
        "standard",
        "operating",
        "documentation"
      ],
      "expectedAnswer": "**Summarizing recall SOP requirements** I need to provide a concise summary of creating a product recall SOP, specifically for New York cannabis regulations. It should include compliance with the Office of Cannabis Management (OCM) and Cannabis Control Board (CCB), referencing 9 NYCRR Part 131 for adult-use and 10 NYCRR Part 1004 for medical cannabis. The SOP must outline that licensees must have a recall plan, maintain records, and notify the OCM within 24 hours regarding any product recalls or adverse events.**Summarizing product recall SOP requirements** I need to create a concise summary for a Standard Operating Procedure (SOP) regarding product recalls, specifically relating to New York's cannabis regulations. The SOP must comply with rules from the Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB), covering both adult-use and medical cannabis. For adult-use, it must reference 9 NYCRR Part 131, while medical cannabis should align with former DOH regulations. I believe it should include plan requirements, record maintenance, and timely notifications to the OCM."
    },
    {
      "questionNum": 4,
      "question": "What are the requirements for testing regular pre-rolls when I bought the raw material from a cultivator that already tested it?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nEven if the flower you buy from a cultivator already comes with a full COA, every *finished product* that leaves your facility (in this case, pre‑rolled joints) must be tested again. The test panel is usually broader than the flower‑only panel because you now have to verify that the **final‑product potency, contaminants, moisture, and any added components** all meet the state‑mandated limits.\n\nBelow is a practical, step‑by‑step checklist that works for most U.S. state programs (California, Colorado, Washington, Oregon, Massachusetts, etc.). If you operate in a different jurisdiction, compare the list with that state’s specific “Finished Product” regulations – the gaps are usually small.\n\n---\n\n## 1️⃣ What the cultivator’s COA covers (and what it **doesn’t**)\n\n| Item | Typically in a flower COA | What you still need to verify |\n|------|---------------------------|------------------------------|\n| **Potency** (THC, CBD, minor cannabinoids) | ✔︎ | ✔︎ Confirm that the blend you actually roll matches the COA (mixing, trimming loss, etc.) |\n| **Pesticides** | ✔︎ | ✔︎ Verify that no contamination was introduced during handling, storage, or rolling (e.g., from contaminated equipment) |\n| **Microbials** (total yeast & mold, *E. coli*, *Salmonella*) | ✔︎ | ✔︎ Test the finished joint for **total yeast & mold** and **pathogens** – rolling papers can harbor microbes |\n| **Heavy Metals** (Pb, As, Cd, Hg) | ✔︎ | ✔︎ Same – metal leaching from metal equipment or packaging must be ruled out |\n| **Residual Solvents** (if flower was extracted) | ✔︎ | ✔︎ Usually not needed for raw flower, but if you add any concentrates, you must test the final joint for solvents |\n| **Terpenes** | Optional | Optional – useful for label claims but not always required by law |\n| **Moisture / Water Activity** | Rarely | ✔︎ Required for smokeable products in many states (to prevent mold growth) |\n| **Foreign Matter / Fibers** | Rarely | ✔︎ Often required for smoked products (e.g., paper, filter contaminants) |\n\n**Bottom line:** The cultivator’s COA gives you a baseline, but you must still perform *finished‑product* testing for potency, contaminants, moisture, and any added materials.\n\n---\n\n## 2️⃣ Minimum Test Panel for a Finished Pre‑Roll (U.S. State‑Level)\n\n| Test | Why it’s needed for a pre‑roll | Typical acceptance limits* |\n|------|-------------------------------|----------------------------|\n| **Potency (THC, Δ‑9‑THC, THCA, CBD, CBDA, minor cannabinoids)** | Confirms label claim, dosing consistency | ±10 % of label claim (state‑specific) |\n| **Moisture Content / Water Activity** | Prevents mold & ensures proper burn | < 12 % moisture (most states) |\n| **Total Yeast & Mold** | Smokeable product can carry spores | ≤ 10⁴ CFU/g (often lower for smoked) |\n| **Pathogenic Bacteria** (*E. coli*, *Salmonella*) | Health risk if inhaled | Not detected |\n| **Pesticides (multi‑residue panel)** | Regulatory limit per state | ≤ state‑specified ppm (often < 0.5 ppm) |\n| **Heavy Metals (Pb, As, Cd, Hg)** |\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1218 (218?1000) | Cost: $0.000000*",
      "duration": 14551,
      "grade": "F",
      "score": 41,
      "grading": {
        "accuracy": 10,
        "completeness": 7,
        "relevance": 11,
        "clarity_structure": 8,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Provides a clear, structured overview of typical finished-product testing considerations",
        "Offers practical, actionable elements like test panels and rationale for each test",
        "Acknowledges jurisdictional variability (suggests checking state rules)"
      ],
      "weaknesses": [
        "Not New York–specific despite the question’s focus; misses NY OCM rules",
        "Asserts that every finished pre-roll must be retested, which conflicts with NY’s potential exemptions for non-infused pre-rolls from a compliant single lot with no additives",
        "Omits NY-specific requirements around lots, sampling, and mechanical processing exemptions",
        "Includes generalized acceptance limits that may not align with NY standards",
        "Answer is truncated and contains extraneous meta text, reducing clarity"
      ],
      "feedback": "Refocus on New York OCM requirements. Clarify that while all final products generally require independent lab testing, NY may allow use of existing compliance results for non-infused pre-rolls made from a single compliant lot with no additives and maintained homogeneity, subject to lot/sampling rules. Outline the specific NY exemptions for mechanical processing, when retesting is triggered (e.g., mixing lots, adding materials, changes affecting homogeneity), and how to document COAs and batch records. Provide NY-specific acceptance criteria and sampling procedures instead of generic state limits.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "board",
        "standard",
        "documentation",
        "document",
        "record",
        "log",
        "testing",
        "test",
        "coa",
        "certificate"
      ],
      "expectedAnswer": "**Summarizing NY pre-roll testing requirements** I need to summarize the requirements for testing pre-rolls when the raw material was already tested by the cultivator. In New York, all final cannabis products must be tested by an independent lab before they can be sold. There are specific rules related to lots, sampling, and some exemptions for mechanical processing. It seems that for non-infused pre-rolls made from a compliant batch, existing compliance testing can suffice if the product is homogeneous with no additives.**Outlining NY testing regulations** I need to summarize the requirements for testing regular pre-rolls when the raw material was already tested by a cultivator in New York. I'll focus on NY regulations related to cannabis product testing. According to NY OCM rules, all final products must be tested by an independent lab before retail sale. There are specific rules for lots, sampling, and some exemptions for non-infused pre-rolls from a single lot that already have compliance testing. I'll clarify these points."
    },
    {
      "questionNum": 5,
      "question": "Can I make an infused pre-roll without retesting it if I am using already tested flower and concentrate?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most regulated markets you **cannot** ship an infused pre‑roll without a fresh laboratory analysis of the finished product, even if the flower and concentrate you used have already been tested. The act of blending, heating, or otherwise processing those inputs creates a *new* product whose potency, contaminant profile, and stability must be verified.\n\nBelow is a concise breakdown of why retesting is required, the regulatory landscape, and practical steps you can take to keep the testing burden as low as possible while staying compliant.\n\n---\n\n## 1. Why the finished pre‑roll is a “new” product\n\n| Factor | How it changes during infusion |\n|--------|--------------------------------|\n| **Potent % (THC, CBD, minor cannabinoids)** | Dilution of concentrate into flower, loss of volatiles during gentle heating, possible decarboxylation differences. |\n| **Terpene profile** | Terpenes can evaporate, oxidize, or redistribute, altering both aroma and perceived potency. |\n| **Residual solvents** | If the concentrate was solvent‑based, any residual solvent can migrate into the flower matrix during mixing/heating. |\n| **Microbial load** | Adding moisture (e.g., from a terpene‑rich concentrate) can raise the water activity of the final roll, potentially supporting mold growth. |\n| **Pesticide / heavy‑metal distribution** | Even if each component is clean, the final blend must be demonstrated to stay below the per‑batch limits set by the state. |\n| **Physical consistency** | Uniformity of dose per joint is a quality‑control issue that regulators often require validated testing for. |\n\nBecause each of those variables can shift, the finished pre‑roll is treated by regulators as a **new batch** that must be independently verified.\n\n---\n\n## 2. Typical regulatory requirements (U.S. state‑level snapshot)\n\n| State | Requirement for “derived” products (e.g., infused pre‑rolls) |\n|-------|-------------------------------------------------------------|\n| **California** | Every finished product must have a COA covering potency, residual solvents, pesticides, heavy metals, and microbial. Using a “derived product” exemption is only allowed for raw flower that is simply packaged, not for blended products. |\n| **Colorado** | A new COA is required for any product whose composition differs from the source material; potency and contaminants must be tested on the final product. |\n| **Oregon** | Finished products must be tested for potency and contaminants; a “derived product” exemption applies only when the product is **identical** to the tested source (no blending or processing). |\n| **Washington** | All manufactured cannabis products, including infused pre‑rolls, need a fresh COA. |\n| **Illinois** | Mandatory testing of the final product for potency, residual solvents, pesticides, heavy metals, and microbiology. |\n| **Canada (federal)** | A new batch of a manufactured product (e.g., “infused joint”) must be tested for potency, contaminants, and stability; a “source material” COA alone is insufficient. |\n\n**Bottom line:** In the vast majority of jurisdictions, the law treats an infused pre‑roll as a *manufactured cannabis product* and therefore requires a **new laboratory analysis** for each batch.\n\n---\n\n## 3. What testing is typically required for an infused pre‑roll\n\n| Test | Why it matters |\n|------|----------------|\n| **Potency (THC, CBD, minor cannabinoids)** | Confirms the labeled dose per joint and verifies that the blend achieved the target ratio. |\n| **Residual solvents** | Especially important if the concentrate was made with butane, propane, ethanol, CO₂, etc. |\n| **P\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1181 (181?1000) | Cost: $0.000000*",
      "duration": 5861,
      "grade": "F",
      "score": 57,
      "grading": {
        "accuracy": 22,
        "completeness": 9,
        "relevance": 13,
        "clarity_structure": 8,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly states that infused pre-rolls generally require final product testing even if inputs were tested",
        "Provides rationale for why blending/infusion creates a new product needing verification",
        "Includes a high-level overview of typical testing panels (potency, residual solvents, contaminants)"
      ],
      "weaknesses": [
        "Does not address New York-specific rules or cite 9 NYCRR Part 130 or OCM guidance as expected",
        "Omits classification detail that infused pre-rolls are treated as manufactured cannabis products in NY and must be tested as finished goods",
        "Fails to cover NY-required elements like final potency per unit, homogeneity/labeling considerations, and contaminant panels tied to the extraction method",
        "No discussion of potential compositing or batch definitions under NY rules",
        "Answer is truncated mid-section and includes irrelevant artifact text, reducing clarity and completeness",
        "Does not distinguish between infused vs non-infused pre-rolls in the NY context"
      ],
      "feedback": "Your core premise—that infused pre-rolls generally require finished-product testing even when inputs are tested—is sound. However, the question calls for a New York–specific summary. Add NY OCM references (9 NYCRR Part 130), clarify that infused pre-rolls are manufactured cannabis products requiring final COAs, list NY-required analytes (potency, residual solvents when applicable, pesticides, heavy metals, microbial/mycotoxins), address total THC per unit/pack and labeling, note any sampling/compositing allowances, and distinguish how non-infused pre-rolls are treated. Remove artifacts and complete the testing section for clarity.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "epa",
        "standard",
        "testing",
        "test",
        "coa"
      ],
      "expectedAnswer": "**Summarizing New York regulations** I need to create a concise summary about New York regulations on retesting infused pre-rolls when using previously tested flower and concentrates. It seems that most states generally require finished product testing, even if the inputs were already tested. The New York Office of Cannabis Management has specific rules for this, including guidelines for adult-use laboratories under 9 NYCRR Part 130. For infused pre-rolls, if they’re classified as “manufactured products,” additional testing may be required, but non-infused pre-rolls might not need full testing if there’s no further processing.**Clarifying infused product testing** When infused with concentrates like kief or hash oil, the product is classified as a \"cannabis product.\" This means it needs potency and contaminant testing for the final form. Testing should cover aspects such as homogeneity, heavy metals, and residual solvents, especially if hydrocarbon extracts are involved. Additionally, total THC per serving or pack and net weight will also require attention. There could be some allowances for compositing during this testing process, but I need to confirm that detail."
    },
    {
      "questionNum": 6,
      "question": "Do I have to show harvest date or production date on infused products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nIn most U.S. states that regulate cannabis‑infused products you **must list a “manufacture/production date” (or a “batch/lot number” that can be traced back to that date)**. A “harvest date” is rarely required on the finished infused product, though some states ask for it on the raw‑cannabis inventory that feeds the infusion process.\n\n---\n\n## 1. What the major states say\n\n| State | Required on the final infused product | Harvest date required? | Typical label fields |\n|-------|---------------------------------------|------------------------|----------------------|\n| **California (Beverage, Edible, Topical, etc.)** | **Manufacture/Production date** (MM/DD/YYYY) **and** “Sell‑by” or “Use‑by” date. | Not required on the consumer label (only on the raw‑cannabis tracking sheet). | Product name, net weight/volume, THC/CBD potency, batch/lot #, QR code, warnings, serving size, allergens, manufacturer info. |\n| **Colorado** | **Manufacture date** (or “Packaging date”) and “Expiration date”. | Not required on the consumer label. | Same as CA plus “Cultivar” (optional) and “Total THC”. |\n| **Oregon** | **Production/Packaging date** and “Expiration date” (must be ≤ 1 yr for edibles). | Not required on the consumer label. | Batch/lot #, potency, allergens, serving size, warnings. |\n| **Washington** | **Production date** (MM/DD/YYYY) and “Expiration date”. | Not required on the consumer label. | Batch/lot #, THC/CBD per serving, warnings, QR code. |\n| **Michigan** | **Manufacturing date** and “Best‑by” date. | Not required on the consumer label. | Batch/lot, potency, warnings, allergens. |\n| **Massachusetts** | **Manufacture date** and “Expiration date”. | Not required on the consumer label. | Batch/lot #, potency, warnings, serving size. |\n\n> **Bottom line:** All of the states above (the ones with the most mature markets) require a *production/manufacture/packaging* date on the consumer‑facing label. None of them mandate a *harvest date* on the finished infused product.\n\n---\n\n## 2. Why the distinction matters\n\n| Reason | Production/Manufacture Date | Harvest Date |\n|--------|-----------------------------|--------------|\n| **Shelf‑life & Safety** | Indicates how long the product has been processed, helping regulators enforce expiration limits (e.g., 1 yr for edibles). | Harvest date is useful for growers to track plant freshness, but once the material is extracted and infused the potency and microbial risk are driven by the *processing* timeline, not the original harvest. |\n| **Traceability** | Tied to batch/lot numbers; allows a regulator to pull the entire production record (extraction, formulation, packaging). | Used internally for seed‑to‑sale tracking, but not required for consumer‑level traceability. |\n| **Consumer Information** | Helps consumers know if a product is “fresh” (especially for vape cartridges or topicals). | Generally not meaningful to the consumer; they care about potency and expiration, not when the plant was cut. |\n\n---\n\n## 3. What you should put on the label (minimum for most states)\n\n1. **Product name & brand**  \n2. **Net weight/volume** (e.g., 10 g, 30 mL)  \n3. **THC / CBD potency** (per serving and per package)  \n4. **Serving size** (for edibles)  \n5. **Manufacture/Production date** (MM/DD/YYYY) – *required*  \n6. **Expiration/“Best‑by” date** – calculated from the manufacture date per state limits (often 1 yr for edibles, 2 \n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1165 (165?1000) | Cost: $0.000000*",
      "duration": 8936,
      "grade": "F",
      "score": 36,
      "grading": {
        "accuracy": 11,
        "completeness": 5,
        "relevance": 8,
        "clarity_structure": 8,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly distinguishes between harvest date and production/manufacture date",
        "Explains the rationale for why production date is more relevant on infused products",
        "Uses a structured format that is easy to scan"
      ],
      "weaknesses": [
        "Does not address New York OCM adult-use (and medical) labeling requirements as expected",
        "Overgeneralizes across states and includes potentially inaccurate state-specific claims",
        "Omits discussion of medical vs adult-use differences",
        "Lacks citations or references to the applicable regulations",
        "Content is truncated/incomplete at the end, reducing clarity and usefulness"
      ],
      "feedback": "The answer provides a general distinction between harvest and production dates, but it fails to address the New York-specific OCM requirements the question calls for, including adult-use vs medical differences and specific label fields (e.g., processor name, license number, lot number, potency, expiration, storage conditions). It also overgeneralizes with potentially incorrect state details and ends abruptly. Focus on NY regulations, clearly state whether harvest or production/packaging dates are required for infused products, note any medical vs adult-use distinctions, and provide concrete, referenced guidance.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "required",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "michigan",
        "illinois",
        "federal",
        "fda",
        "standard",
        "record"
      ],
      "expectedAnswer": "**Summarizing product labeling rules** I need to summarize New York's regulations around showing harvest or production dates on infused products. It falls under product testing and compliance, particularly the adult-use cannabis regulations from the Office of Cannabis Management. Key details from the 2023/2024 regulations include requirements for the label such as the processor's name, license number, lot number, THC/CBD content, expiration date, and storage conditions. I’ll ensure to capture all critical facts and state-specific information clearly.**Considering medical vs adult-use differences** I'm thinking about the differences between medical and adult-use products. One key aspect I might need to consider is the requirement for a production or packaging date. This could help in understanding the regulations that apply to each category. It's essential to distinguish them correctly, ensuring I'm clear about any specific requirements or guidelines related to these differences. Overall, I'll keep this in mind as I explore further."
    },
    {
      "questionNum": 7,
      "question": "Are there different rules for various types of infused products related to this same question?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "### Yes – the rules differ noticeably among the main categories of cannabis‑infused products. Below is a concise overview of the most common product types and the key regulatory distinctions that apply in most U.S. jurisdictions (state‑level rules can vary, so always check the specific state’s cannabis board for exact limits).\n\n| Product Type | Primary Regulatory Focus | Typical Limits & Requirements |\n|--------------|--------------------------|--------------------------------|\n| **Edibles (food, candy, baked goods, etc.)** | • **Dosage per serving**<br>• **Package size**<br>• **Labeling & child‑proof packaging** | • ≤ 10 mg THC per serving (most states)<br>• ≤ 100 mg THC per package (some states allow 200 mg)<br>• Mandatory potency, ingredient, allergen, and warning statements<br>• Must be sold in tamper‑evident, child‑resistant containers |\n| **Beverages (sodas, teas, coffees, etc.)** | • **Dosage per container**<br>• **Volume & potency**<br>• **Labeling of “non‑alcoholic”** | • Usually ≤ 10 mg THC per serving; ≤ 100 mg per container<br>• Must list total THC, CBD, and any other cannabinoids<br>• Must include “Contains Cannabis” and health warnings |\n| **Tinctures & Liquid Extracts** | • **Concentration limits**<br>• **Drop‑per‑serving clarity**<br>• **Packaging** | • Often limited to ≤ 100 mg THC per container (some states allow up to 250 mg)<br>• Must provide clear dosage instructions (e.g., “1 ml = 10 mg THC”)<br>‑ Child‑resistant bottle required |\n| **Topicals (creams, balms, patches, transdermal gels)** | • **THC vs. CBD content**<br>• **Claims about therapeutic effects** | • Many states treat THC‑topicals like non‑psychoactive products, allowing higher THC levels (e.g., up to 500 mg per package) if no oral ingestion claim is made<br>‑ Must not claim medical benefits unless licensed as a medical product |\n| **Capsules & Softgels** | • **Dose per capsule**<br>• **Packaging** | • Typically ≤ 10 mg THC per capsule; ≤ 100 mg per bottle<br>‑ Child‑resistant packaging required |\n| **Suppositories & Other Novel Delivery** | • **Limited by state-specific “novel product” rules** | • Often subject to stricter testing, labeling, and may be prohibited in some states until a formal rule is adopted |\n\n#### Common Threads Across All Product Types\n| Requirement | Why It Matters |\n|-------------|----------------|\n| **Lab Testing** | Must meet state‑mandated potency, pesticide, residual solvent, and microbial standards. |\n| **Packaging** | Child‑resistant, tamper‑evident, and opaque (no visible product) are usually required. |\n| **Labeling** | Mandatory: product name, total THC/CBD, serving size, number of servings, batch/lot number, QR code for traceability, health warnings, and “Do not use if pregnant” (if applicable). |\n| **Advertising Restrictions** | No appeal to minors, no health claims for non‑medical products, limited placement (often only on‑premise). |\n| **Inventory Tracking** | Integration with the state’s seed‑to‑sale system (e.g., METRC, BioTrackTHC). |\n\n#### State‑Specific Variations (Examples)\n| State | Edibles | Beverages | Topicals |\n|-------|---------|-----------|----------|\n| **California** | 10 mg per serving, 100 mg per package | 10 mg per serving, 100 mg per package | No THC limit if THC is “non‑psychoactive” (e.g., topical only) |\n| **Colorado** | 10 mg per serving, 100 mg per package | Same as edibles | 500 mg per package allowed |\n| **Oregon** | 10 mg per serving, 100 mg per package | Same as edibles | 500 mg per package (if no oral claim) |\n| **Washington** | 10 mg per serving, 100 mg per package | Same as edibles | 500 mg per package (non‑oral) |\n\n#### Quick Checklist for Launching a New Infused Product\n1. **Determine product category** → apply the correct dosage and packaging limits.  \n2. **Run a compliant lab test** → confirm potency, contaminants, and stability.  \n3. **Design child‑resistant, tamper‑evident packaging** → meet state visual guidelines.  \n4. **Create a label** → include all required data points (potency, serving size, warnings, QR code).  \n5. **Register the product in the state seed‑to‑sale system** → obtain batch/lot numbers.  \n6. **Review advertising rules** → ensure no minors‑targeted content or unsubstantiated health claims.  \n\n#### Resources\n- **State Cannabis Regulatory Agency Websites** (e.g., California Department of Cannabis Control, Colorado Department of Revenue – Marijuana Enforcement Division).  \n- **National Cannabis Industry Association (NCIA) Guidelines** – offers a consolidated view of common state rules.  \n- **Leafly & New Frontier Data** – up‑to‑date regulatory trackers per state.  \n\n**Bottom line:** Yes, each infused product type carries its own set of limits and compliance requirements, especially around dosage per serving, total package potency, packaging design, and labeling. Always start by confirming the specific state’s rulebook for the product class you’re developing. If you need a deep dive into a particular state’s regulations or help drafting compliant labels, let me know!\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1561 (168?1393) | Cost: $0.000000*",
      "duration": 16036,
      "grade": "B",
      "score": 85.66666666666667,
      "grading": {
        "length": "Pass",
        "keywords": "13/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "2/5 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "mandatory",
        "must",
        "state",
        "federal",
        "standard",
        "testing",
        "test",
        "lab",
        "potency",
        "pesticide",
        "microbial",
        "mycotoxin"
      ],
      "expectedAnswer": ""
    },
    {
      "questionNum": 8,
      "question": "What are the requirements in my state for me to be able to introduce or infuse cannabis or botanical-derived terpenes into my products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a **high‑level checklist** you can use once you know which state you’re operating in.  Most U.S. states follow a very similar regulatory framework, so you can plug the specific numbers or agency names in for your jurisdiction.\n\n---\n\n## 1. Determine the Legal Landscape in Your State  \n\n| Question | Why it matters | Typical answer by state |\n|----------|----------------|------------------------|\n| **Is cannabis legal (medical, adult‑use, or both)?** | Determines whether you can work with **cannabis‑derived** terpenes at all. | Some states allow only medical; others allow both. |\n| **Does the state differentiate “cannabis‑derived” vs. “botanical‑derived” terpenes?** | Botanical terpenes (e.g., from citrus, pine, lavender) may be permitted even where cannabis‑derived terpenes are restricted. | Many states treat them as a separate “flavoring” category, but still require safety data. |\n| **Which agency issues licenses?** | You’ll apply to the correct regulator (e.g., Department of Health, Cannabis Control Board, Agriculture Dept.). | Varies by state. |\n\n**Action:** Look up your state’s “Cannabis Control Board” or “Department of Health – Marijuana Program” website and locate the “Regulations / Statutes” section.  \n\n---\n\n## 2. Obtain the Correct License(s)\n\n| License Type | Typical activities covered | Typical requirements |\n|--------------|---------------------------|----------------------|\n| **Cultivation/Propagation** | Growing cannabis plants (source of terpene isolates). | Background check, security plan, seed‑to‑sale tracking. |\n| **Processor/Manufacturer** | Extraction, isolation, formulation, infusion. | GMP/ISO‑22716 compliance, SOPs, QA/QC labs, batch records. |\n| **Packager/Labeler** | Final product packaging, labeling. | Label approval, child‑resistant packaging (if THC >0.1 %). |\n| **Wholesale/Distributor** | Moving product between licensed entities. | Transport manifest, tracking system. |\n| **Retail/Dispensary** (if you plan to sell directly) | Point‑of‑sale to consumer. | Store security, inventory controls. |\n\n*If you only use **botanical‑derived** terpenes (non‑cannabis), many states treat you like a food‑/cosmetic‑manufacturer, but you may still need a **food‑manufacturing** or **cosmetics** license.*\n\n---\n\n## 3. Product‑Specific Regulatory Limits  \n\n| Product Class | THC / CBD Limits (typical) | Terpene Limits | Other constraints |\n|---------------|---------------------------|----------------|-------------------|\n| **Edibles** | ≤ 10 mg THC per serving; ≤ 100 mg per package (varies). | No explicit terpene cap, but total THC‑equivalent must stay under the limit. | Must be made in a **food‑grade** facility, undergo **potency & contaminant testing**, child‑resistant packaging. |\n| **Topicals** | Often no THC limit, but many states cap at **0.3 % THC** or require it be “non‑psychoactive”. | Terpene concentration usually limited to **≤ 5 %** of total product weight. | Must meet **cosmetic** safety standards, label with “for external use only”. |\n| **Tinctures/OTC** | Same as edibles for THC per mL (e.g., ≤ 100 mg THC per container). | Terpene concentration often limited to **≤ 10 %** of total volume. | Must be packaged in child‑resistant containers, include **\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1221 (221?1000) | Cost: $0.000000*",
      "duration": 13180,
      "grade": "F",
      "score": 21,
      "grading": {
        "accuracy": 6,
        "completeness": 3,
        "relevance": 4,
        "clarity_structure": 5,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear high-level structure and checklist format",
        "Acknowledges licensing, QA/QC, and testing considerations in general terms"
      ],
      "weaknesses": [
        "Not state-specific to New York and does not reference NY OCM/CRTA regulations",
        "Misses key terpene rules (GRAS/food-grade requirement, labeling source, restrictions on flavoring products attractive to minors)",
        "Contains questionable or inaccurate \"typical\" limits (e.g., terpene % caps, child-resistant threshold, THC limits for topicals)",
        "Omits bans/restrictions on synthetic cannabinoids and harmful additives per NY rules",
        "Fails to cover excipient requirements and additive disclosure",
        "Answer is truncated and includes irrelevant meta text"
      ],
      "feedback": "The response is a generic checklist and does not address New York’s specific infusion and terpene regulations. To meet the expected standard, focus on NY OCM/CRTA adult-use rules: allow only naturally occurring cannabis or botanical terpenes that are food-grade/GRAS, require ingredient/common name and source on labels, prohibit additives appealing to minors, and ban synthetic cannabinoids and harmful diluents. Include testing, excipient requirements, and state citation-level details in a concise 100–200 word summary.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "michigan",
        "fda",
        "epa",
        "agency",
        "board",
        "sop"
      ],
      "expectedAnswer": "**Summarizing cannabis compliance requirements** I need to create a concise summary for a question about New York's cannabis infusion regulations. The focus is on product testing and infusion rules, especially concerning terpenes. The summary should cover the main conclusion, key requirements, regulatory details, and state-specific info, without any commentary. I'll ensure it addresses the NY OCM/CRTA adult-use regulations, noting the restrictions on flavor additives, terpenes, synthetic cannabinoids, and other potentially harmful additives. The goal is 100-200 words.**Clarifying terpene regulations in NY** New York permits \"naturally occurring terpenes\" from cannabis or botanical sources as long as they meet certain criteria. They need to be food-grade and generally recognized as safe (GRAS). Additionally, these terpenes cannot be used for flavoring products aimed at minors. It's essential to list them on the ingredient panel with their common or usual name and source. There are also specific excipient requirements to consider, which will be crucial for compliance."
    },
    {
      "questionNum": 9,
      "question": "Does this vary for different products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "The answer depends on which part of the cannabis business you’re asking about—**licensing, testing, labeling, packaging, or distribution**—because each product category has its own set‑up.\n\n| Product Type | Key Requirements that **vary** |\n|--------------|--------------------------------|\n| **Flower / Bud** | • THC/CBD potency testing (usually 0.5 % ± 0.1 % tolerance)<br>• Pesticide & microbial limits<br>• Dry‑weight packaging limits (e.g., 1 g, 3.5 g, 7 g)<br>• No added sugars or fats (so no “edible” claims) |\n| **Edibles** | • Total THC per package (often ≤ 10 mg in many states)<br>• Separate labeling for “dose per serving”<br>• Child‑resistant packaging mandatory<br>• Additional nutrition facts and ingredient list |\n| **Concentrates / Extracts** | • Potency testing (often tighter ± 0.1 % tolerance)<br>• Solvent residual limits (e.g., butane, ethanol)<br>• Specific packaging (e.g., tamper‑evident, child‑proof)<br>• May require separate “concentrate” license |\n| **Topicals** | • No THC dose limits (since not ingested), but potency still disclosed<br>• Ingredient safety data sheets required<br>• Labeling must state “for external use only” |\n| **Tinctures & Capsules** | • Dose limits similar to edibles (e.g., ≤ 10 mg THC per serving)<br>• Must be in child‑resistant containers<br>• Clear “dose per serving” and “total dose” labeling |\n| **Beverages** | • THC/CBD limits per fluid ounce (often ≤ 5 mg per 10 ml)<br>• Full nutrition facts panel<br>• Separate “non‑alcoholic” labeling requirements |\n\n### Bottom line\n- **Regulatory compliance, testing thresholds, packaging, and labeling rules all shift from one product class to another.**\n- Even within a single class (e.g., edibles), requirements can differ by **state/province** and by **product format** (bars vs. gummies vs. chocolates).\n\nIf you let me know the specific product you’re thinking about (flower, gummies, vape cartridges, etc.) and the jurisdiction you’re operating in, I can give you the exact list of variations you’ll need to follow.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 794 (159?635) | Cost: $0.000000*",
      "duration": 9868,
      "grade": "B",
      "score": 82.33333333333334,
      "grading": {
        "length": "Pass",
        "keywords": "14/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "0/2 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "federal",
        "epa",
        "standard",
        "testing",
        "test",
        "lab",
        "potency",
        "pesticide"
      ],
      "expectedAnswer": ""
    },
    {
      "questionNum": 10,
      "question": "What are the labeling requirements for packaged concentrates?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a practical “cheat‑sheet” of the **core labeling elements that every U.S. state currently requires for packaged cannabis concentrates** (wax, shatter, live‑ resin, distillate, etc.).  The list is organized by **universal requirements** (common to most jurisdictions) and then **state‑specific add‑ons** for the six largest markets (CA, CO, WA, OR, MA, and NV).  If you are selling in a different state, simply cross‑reference the universal items with that state’s cannabis‑specific rulebook—most of the language can be reused with only a few tweaks.\n\n---\n\n## 1. Universal (most‑states) Requirements  \n\n| # | Requirement | What to Include | Typical Placement / Formatting |\n|---|-------------|-----------------|--------------------------------|\n| 1 | **Product Identity** | Brand name + product type (e.g., “Blue Dream Live Resin”) | Top‑center, prominent, legible ≥ 2 mm font |\n| 2 | **Net Quantity** | Weight in grams (or milligrams for “micro‑doses”) – e.g., “0.5 g” | Bottom‑right, bold |\n| 3 | **Potency / Cannabinoid Profile** | • Total THC (Δ⁹‑THC) % <br>• Total CBD % <br>• Major minor cannabinoids if > 0.1 % (CBG, CBN, THCV) | Usually a **“THC: 85 % (850 mg/g)”** style table. Must be derived from a **COA** (lab‑tested). |\n| 4 | **Batch / Lot Number** | Manufacturer‑assigned alphanumeric code (e.g., “B2024‑001‑A”) | Near the potency table |\n| 5 | **Production / Expiry / “Use By” Date** | • Production date (optional in some states) <br>• Expiration or “Best‑if‑used‑by” (typically 12–24 mo from production for concentrates) | Bottom‑left |\n| 6 | **Manufacturer / Distributor Information** | • Business name <br>• Physical address <br>• Contact phone/e‑mail <br>• State license number (e.g., “License # 23‑12345‑A”) | Bottom‑center |\n| 7 | **Warning Statements** | • “Keep out of reach of children and pets.” <br>• “For adult use only. Must be 21+ (or legal age in state).” <br>• “Do not operate machinery or drive while under the influence.” <br>• “Contains THC – may cause psychoactive effects.” | Prominent, often in a red box or bold font |\n| 8 | **Child‑Resistant / Tamper‑Evident Packaging** | Must meet the state’s **ASTM D3475‑21** (or equivalent) child‑resistant standard. Tamper‑seal (e.g., shrink band) must be visible. | Not a label element per se, but the packaging must be certified and the label may note “Child‑Resistant” |\n| 9 | **QR Code / Digital COA Link** | Directs to the lab’s Certificate of Analysis (COA) showing potency, pesticides, residual solvents, mycotoxins, heavy metals. | Usually lower‑right corner; size ≥ 5 mm × 5 mm |\n|10| **Allergen / Ingredient Disclosure** | If any non‑cannabis additives (flavorings, terpenes, carrier oils), list them. | Small font, under “Ingredients” heading |\n|11| **Universal Symbol** | Many states require the **“Cannabis Leaf”** or a state‑specific symbol (e.g., California’s “C‑B” badge) to indicate a regulated product. | Top‑\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1169 (169?1000) | Cost: $0.000000*",
      "duration": 11019,
      "grade": "F",
      "score": 37,
      "grading": {
        "accuracy": 12,
        "completeness": 6,
        "relevance": 6,
        "clarity_structure": 7,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, checklist-style structure with practical label elements (identity, net quantity, potency, batch/lot, manufacturer info, warnings)",
        "Acknowledges COA/lab testing linkage and ingredient disclosure",
        "Mentions child-resistant and tamper-evident packaging considerations"
      ],
      "weaknesses": [
        "Not New York-specific; omits 9 NYCRR Part 128 and New York OCM rules the question expects",
        "Misses PDP requirements for NY (brand/product form, net weight in metric, amount per serving and total, potency on PDP)",
        "Does not include NY-required concentrate-specific warnings and required THC/CBD display in mg per serving and per package, serving size, and number of servings",
        "Overgeneralizes with inaccuracies (QR code/COA and ASTM D3475 not universally required; font sizes and symbols vary by state)",
        "Truncated content (universal symbol section cut off) and no citation or alignment to NY standards"
      ],
      "feedback": "The answer is broadly structured and practical, but it fails to address New York’s specific labeling requirements expected here. Refocus on NY (9 NYCRR Part 128): include PDP elements (brand, product form, net weight metric, total THC/CBD in mg per serving and per package, serving size and number of servings), ingredient/terpene listing with sources, lot/batch, licensee info, manufacture/expiration dates, storage, NY universal symbol, and NY-mandated warnings (21+, impairment, pregnancy/breastfeeding, health risks, poison control, and concentrate/high-THC warnings). Avoid claiming universal requirements (e.g., QR codes, ASTM D3475) unless they are state-specific to NY.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "required",
        "mandatory",
        "state",
        "federal",
        "fda",
        "board",
        "standard",
        "coa",
        "lab",
        "potency",
        "quality",
        "control",
        "batch"
      ],
      "expectedAnswer": "**Summarizing labeling requirements** I need to create a concise summary about labeling requirements for cannabis concentrates in New York. This includes outlining specific regulations from the Cannabis Control Board, focusing on key facts like product identity, net weight, cannabinoid content, and serving sizes. Regulations state that terpenes and ingredients must be listed, and there are additional potency warnings for concentrates. I should ensure I cover essential details like manufacturing and expiration dates while adhering to state-specific information.**Recapping New York's PDP requirements** In New York, I need to remember that the principal display panel (PDP) must include several key elements. This includes the brand name, the product form, and both the amount per serving and the total amount. Additionally, the net weight needs to be displayed in metric units, along with the potency information. It’s crucial to get these details right when summarizing labeling requirements for products in New York.**Summarizing labeling requirements** I need to produce a concise summary about labeling requirements for packaged concentrates in New York. I’ll outline the specific cannabis packaging and labeling rules, particularly from 9 NYCRR Part 128. Key details will include product identity, net weight, cannabinoid content (total THC and CBD), serving size, and lot/batch information. Instructions regarding potency and usage will also be important. I want to ensure I capture criti..."
    },
    {
      "questionNum": 11,
      "question": "Is my edibles packaging compliant to national, state, and local regulations?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a quick “self‑check” you can run right now, followed by the next steps you can take (including routing you to a specialist if you’d like a deeper review).\n\n---\n\n## 1️⃣ Quick Self‑Check – Does Your Edible Package Meet the Basics?\n\n| Requirement | What to Verify | Typical U.S. Standard |\n|------------|----------------|----------------------|\n| **Federal (US FDA/USDA)** | • No health claims unless FDA‑approved<br>• Ingredient list & nutrition facts (if > 0.5 g THC per serving)<br>• Net weight, batch/lot #, manufacturer info<br>• Child‑resistant, tamper‑evident | 21 CFR 184.1900‑184.1905 (food) + 21 CFR 1308.11 (cannabis) |\n| **State (example: CO, CA, NY, etc.)** | • State‑specific label fields (e.g., “THC % per serving”, “Servings per package”)<br>• State‑approved warning statements (e.g., “This product may be harmful if…”)<br>• QR code linking to lab results (required in CO, CA, MA, etc.)<br>• Packaging must be child‑resistant & not appealing to children (no cartoon characters) | Varies by state – see each state’s “Cannabis Packaging & Labeling” rulebook |\n| **Local/County/City** | • Additional graphic or wording limits (e.g., “No advertising within 500 ft of schools”)<br>• Local licensing numbers on the label<br>• Specific size/shape restrictions (some cities ban “edible candy” look‑alikes) | Check the municipality’s cannabis ordinance or contact the local licensing authority |\n| **General Safety Features** | • Child‑resistant (CR) packaging meeting ASTM D3475‑20 or ISO 11625‑1<br>• Tamper‑evident seal<br>• No “flavor‑enhancing” additives that could attract kids | Required in every jurisdiction that permits edibles |\n| **Label Content Checklist** | 1. **Brand name & product name**<br>2. **Net weight** (g or ml)<br>3. **THC & CBD potency** (per serving & per package)<br>4. **Number of servings**<br>5. **Ingredients** (including allergens)<br>6. **Manufacturer & distributor contact**<br>7. **Batch/lot # & expiration date**<br>8. **Warning statements** (e.g., “Keep out of reach of children”, “Do not operate a vehicle”)<br>9. **QR code** linking to lab results (if required) | All must be legible, in English (and often the state’s official language) |\n| **Packaging Material** | • Must be **child‑resistant** (CR) and **tamper‑evident**<br>• No transparent “candy‑style” packaging in many states (e.g., CO, MA)<br>• Must not be “misbranded” (e.g., look like non‑cannabis food) | ASTM D3475‑20, ISO 11625‑1, state‑specific visual guidelines |\n\n---\n\n## 2️⃣ What I Need From You to Give a Definitive Answer\n\n| Info Needed | Why It Matters |\n|------------|----------------|\n| **State & locality** (e.g., “Los Angeles, CA”) | Determines the exact rule set (state + city ordinances). |\n| **Full label copy** (text & images) | I can compare each element to the required fields. |\n| **Packaging type** (e.g., gummy, chocolate, beverage) | Some states have different limits per product type (e.g., max 10 mg THC per serving in CO). |\n| **THC/CBD potency** (per serving & per package) | Needed for potency‑related limits and warning statements. |\n|\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1172 (172?1000) | Cost: $0.000000*",
      "duration": 7862,
      "grade": "F",
      "score": 41,
      "grading": {
        "accuracy": 8,
        "completeness": 8,
        "relevance": 10,
        "clarity_structure": 11,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, organized checklist format and requests for needed information",
        "Covers core concepts like child-resistant and tamper-evident packaging",
        "Provides a general label content checklist (brand, net weight, potency, batch, warnings)"
      ],
      "weaknesses": [
        "Fails to address New York-specific OCM requirements expected in the answer",
        "Incorrect federal framing: FDA does not provide cannabis THC edible labeling rules; citing 21 CFR 1308.11 (DEA scheduling) as packaging guidance is misleading",
        "Incorrect standards cited (e.g., ISO 11625-1); common CR standards are 16 CFR 1700.20, ISO 8317, ASTM D3475 classification",
        "Nonsensical threshold: “nutrition facts if > 0.5 g THC per serving” (500 mg THC is far above state limits and not a valid rule)",
        "Misstates QR code requirements (not universally required in CA/CO/MA)",
        "Omits NY-specific elements: universal THC symbol, plain/neutral packaging and youth-appeal restrictions (colors/images), opacity requirements, and 2023–2024 OCM updates",
        "Includes extraneous meta line about agent/tokens which reduces professionalism"
      ],
      "feedback": "The answer is well-structured but contains several factual errors and misses the New York-specific guidance expected. Replace the federal references with accurate context (no FDA THC edible labeling regime), correct the child-resistant standards (16 CFR 1700.20, ISO 8317), remove the erroneous 0.5 g THC threshold, and fix QR-code claims. Focus on New York OCM rules: child-resistant, tamper-evident, opaque/plain packaging not appealing to under-21, universal NY THC symbol, THC per serving/total, serving size, ingredients/allergens, nutrition facts when required, and the 2023–2024 OCM updates limiting bright colors and youth-oriented imagery. Provide a NY-specific compliance checklist and cite OCM guidance.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "must",
        "state",
        "federal",
        "epa",
        "board",
        "metrc",
        "standard",
        "testing",
        "test",
        "certificate",
        "lab"
      ],
      "expectedAnswer": "**Researching packaging compliance** I need to create a summary addressing whether edibles packaging is compliant with regulations in New York. I'll focus on compliance requirements for cannabis edible packaging, highlighting important aspects like child-resistant features, tamper-evident seals, and keeping the packaging opaque. New York's OCM regulations mandate that packaging should not appeal to those under 21 and may include restrictions on bright colors. I'll note that recent litigation in 2023 led to updates in packaging rules, emphasizing the importance of adhering to these standards.**Summarizing packaging requirements** For 2024 in New York, packaging for cannabis edibles needs to meet several crucial requirements. It must be child-resistant and tamper-evident, and also not be misleading or appealing to youth. Essential information includes the universal THC symbol, the amount of THC per serving as well as the total, serving size, ingredients, allergens according to FDA rules, and nutrition facts. Making sure all these elements are present is vital for compliance!**Summarizing packaging compliance** I need to provide a summary about edibles packaging regulations in New York to answer the question about compliance with national, state, and local standards. Specifically, I should mention that packaging must be child-resistant, tamper-evident, opaque, and not appealing to children, and it must adhere to plain packaging rules. I also recall recent updates from the New Yo..."
    },
    {
      "questionNum": 12,
      "question": "When is childproof packaging required for certain cannabis products?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Child‑proof (child‑resistant) packaging is required for virtually every cannabis product that is sold to consumers.**  The exact trigger points vary a little by jurisdiction, but the core requirements are driven by federal law (the 2018 Farm Bill) and are echoed in virtually every state‑level cannabis‑regulation framework.\n\nBelow is a quick‑reference guide that you can use when you need to determine whether a product must be in child‑resistant packaging.\n\n---\n\n## 1. Federal Baseline (U.S.)\n\n| Requirement | What the law says | Typical products covered |\n|------------|-------------------|--------------------------|\n| **Child‑Resistant Packaging (CRP) required** | All “cannabis products” defined as any product containing a **cannabinoid** (THC, CBD, etc.) that is intended for human consumption, **except the raw plant material**. The packaging must meet **ASTM F2513‑13** (or later) standards for child‑resistance. | • Edibles (gummies, chocolates, baked goods, beverages)  <br>• Concentrates (shatter, wax, dabs, vape cartridges)  <br>• Tinctures, oils, syrups, sublingual sprays  <br>• Topicals (creams, balms, transdermal patches)  <br>• Capsules, tablets, lozenges  <br>• Any product that is **not** the dried flower or leaf in its natural state |\n| **Exception** | **Raw, unprocessed flower or leaf** (e.g., buds, trim, shake) that is sold in its natural, unprocessed form **does not** need CRP, but it must be in a **tamper‑evident** container. | Dried flower, pre‑rolled joints (if the joint itself is the final product) |\n| **Labeling** | The package must also display a **“Child‑Resistant Packaging”** symbol and a **“Keep out of reach of children”** warning. | All CRP‑required items |\n| **Testing & Certification** | The packaging supplier must provide a **Certificate of Compliance** showing the product passed ASTM F2513 testing. | All CRP‑required items |\n\n---\n\n## 2. State‑Specific Triggers (most common)\n\n| State | When CRP is required | Notable nuances |\n|-------|---------------------|-----------------|\n| **California** | All “cannabis products” **except** the dried flower, leaves, and pre‑rolled joints. | Edibles, concentrates, topicals, tinctures, and any product with a THC/CBD concentration >0.3% must be CRP. |\n| **Colorado** | Same as federal: everything **except** the raw flower. | Colorado also requires a **“Child‑Resistant”** symbol on the front of the package. |\n| **Oregon** | All “cannabis products” **except** the flower. | Requires a **“CRP”** symbol and a **tamper‑evident** seal. |\n| **Washington** | All “cannabis products” **except** the flower. | Must meet **ASTM F2513‑13** and include a **“Keep out of reach of children”** statement. |\n| **Illinois** | All “cannabis products” **except** the flower. | Additional requirement: a **“Child‑Resistant”** icon and a **“Do not use if pregnant”** warning on edibles. |\n| **Massachusetts** | All “cannabis products” **except** the flower. | Requires a **“Child‑Resistant”** symbol and a **“Keep out of reach of children”** statement. |\n| **Michigan** | All “cannabis products” **except** the flower. | Must meet **ASTM F2513‑13** and include a **tamper‑evident** closure. |\n| **New York** | All “cann\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1168 (168?1000) | Cost: $0.000000*",
      "duration": 4552,
      "grade": "F",
      "score": 23,
      "grading": {
        "accuracy": 6,
        "completeness": 3,
        "relevance": 6,
        "clarity_structure": 6,
        "practical_value": 2,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Recognizes that child-resistant packaging is generally required for consumer cannabis products",
        "Attempts to provide a structured, quick-reference guide"
      ],
      "weaknesses": [
        "Misstates a federal baseline (2018 Farm Bill does not set child-resistant packaging rules for marijuana products)",
        "Cites incorrect/irrelevant standards (e.g., ASTM F2513-13) and a non-existent federal CR symbol requirement",
        "Provides inaccurate exceptions (e.g., implying raw flower/pre-rolls often exempt) and generic state claims",
        "Fails to address New York-specific requirements or cite 9 NYCRR Part 128 and PPPA (16 CFR 1700)",
        "Omits the key point that multi-serving edibles must be resealable and remain child-resistant after opening",
        "Answer is truncated and incomplete"
      ],
      "feedback": "The response is broadly framed and contains significant inaccuracies. It should focus on New York OCM requirements: all adult-use cannabis products must be in child-resistant and tamper-evident packaging meeting PPPA (16 CFR 1700), with multi-serving edibles requiring resealable packaging that remains child-resistant after first opening (9 NYCRR Part 128). Remove incorrect federal claims, fix standards references, and provide precise NY-specific triggers and citations.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "illinois",
        "federal",
        "standard",
        "lab",
        "lot",
        "edible"
      ],
      "expectedAnswer": "**Summarizing childproof packaging regulations in NY** I need to gather a concise summary regarding when childproof packaging is required for certain cannabis products in New York. I'll focus on key requirements, regulatory details, and state-specific information relating to adult-use packaging standards set by the Office of Cannabis Management (OCM). Apparently, packaging must be child-resistant and tamper-evident for all cannabis products, aligned with the Poison Prevention Packaging Act. I'll reference the relevant sections from 9 NYCRR Part 128 as well.**Explaining multi-serving edible packaging requirements** I need to clarify that packaging for multi-serving edibles must be resealable while still maintaining its child-resistant properties even after being opened. This is crucial to ensure ongoing safety after the product has been accessed, so it effectively prevents children from easily getting to the contents. It’s an important aspect to keep in mind when discussing childproof packaging regulations in the context of food safety and compliance.**Summarizing childproof packaging regulations** I need to create a concise summary about when childproof packaging is necessary for certain cannabis products in New York. The summary must include key requirements, critical regulatory details, and state-specific information related to adult-use packaging standards from the Office of Cannabis Management (OCM). New York mandates child-resistant and tamper-evident packaging for all c..."
    },
    {
      "questionNum": 13,
      "question": "Can I use leftover packaging labels from last month if they’re still accurate?",
      "category": "labeling-packaging-compliance",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 3703,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "compliance",
      "agentMatch": false
    },
    {
      "questionNum": 14,
      "question": "How potent can our edibles be?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "formulation",
      "agentMatch": true,
      "response": "**How Potent Can an Edible Be? – A Practical Overview**\n\n| Factor | Typical Upper Limit | Notes & Safety Considerations |\n|--------|--------------------|--------------------------------|\n| **Legal / Market‑place caps** | **10 mg THC per serving** (most U.S. states, Canada, EU) | Required by law in many jurisdictions; exceeding this may make the product non‑compliant. |\n| **Maximum loading in the matrix** | **5 % w/w total cannabinoids** (≈50 mg THC per gram of product) | Determined by the solubility of cannabinoids in the base (e.g., butter, oil, gelatin) and by texture/organoleptic limits. |\n| **Practical formulation ceiling** | **30–40 mg THC per serving** for “high‑potency” products (often sold as “premium” or “medical‑strength”) | Achievable with concentrated isolates or distillates; requires rigorous dosing control and clear labeling. |\n| **Extreme‑strength specialty products** | **>100 mg THC per serving** (e.g., “dose‑packs”, “micro‑dosing” kits) | Used only in medical or research contexts; must include extensive warnings, child‑proof packaging, and be sold to qualified patients. |\n| **CBD‑only edibles** | Up to **300 mg CBD per serving** (some markets allow very high CBD) | Limited by taste, GI tolerance, and potential liver enzyme interactions at very high doses. |\n\n---\n\n## 1. What Sets the Upper Limit?\n\n1. **Regulatory ceilings** – Most states/countries set a per‑serving THC limit (10 mg is common). Exceeding it makes the product illegal for retail.\n2. **Formulation physics** – THC and CBD are lipophilic; they dissolve best in fats. A typical oil or butter can hold ~5 % w/w total cannabinoids before the mixture becomes gritty or separates.\n3. **Safety & consumer tolerance** – Doses >30 mg THC can cause anxiety, tachycardia, or severe impairment in naïve users. Professional guidance and clear labeling are mandatory.\n4. **Stability** – High cannabinoid loads increase the risk of oxidation. Antioxidants (e.g., tocopherols) and opaque, airtight packaging become essential.\n\n---\n\n## 2. Quick “How‑Much” Calculator\n\nAssume you’re making 1 kg of chocolate ganache using a 5 % w/w total cannabinoid load (all THC for simplicity).\n\n| Step | Calculation | Result |\n|------|-------------|--------|\n| Desired THC % | 5 % w/w | 0.05 kg THC = **50 g** |\n| Convert to mg | 50 g × 1,000 mg/g | **50,000 mg THC** |\n| Servings per batch | 1 kg ÷ 20 g per piece (typical bar) | 50 pieces |\n| THC per serving | 50,000 mg ÷ 50 | **1,000 mg** (far above any legal limit) |\n\n**Real‑world adjustment:** To hit a legal 10 mg/serving target, you’d only need **0.5 % w/w** THC (≈10 g THC in the 1 kg batch).  \n\n---\n\n## 3. Practical Tips for Maximizing Potency While Staying Safe\n\n| Tip | Why it matters |\n|-----|----------------|\n| **Use high‑purity distillate or isolate** (≥95 % THC) | Reduces bulk volume needed, improves homogeneity, and eases dosing calculations. |\n| **Emulsify with lecithin or polysorbate‑80** | Improves cannabinoid dispersion, allowing higher loading without grainy texture. |\n| **Add antioxidants (e.g., vitamin E, rosemary extract)** | Slows oxidation, preserving potency over the product’s shelf life. |\n| **Standardize batch testing** | Run HPLC‑UV/FL\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1202 (202?1000) | Cost: $0.000000*",
      "duration": 7019,
      "grade": "F",
      "score": 51,
      "grading": {
        "accuracy": 13,
        "completeness": 10,
        "relevance": 12,
        "clarity_structure": 11,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, well-structured layout with practical sections and examples",
        "Recognizes common per‑serving THC cap (10 mg) and includes CBD mention",
        "Provides formulation context and actionable formulation tips"
      ],
      "weaknesses": [
        "Misstates jurisdictional rules (e.g., Canada is 10 mg THC per package, not per serving; EU is not harmonized at 10 mg/serving)",
        "Omits key per‑package cap (typically 100 mg/package in many adult‑use U.S. states)",
        "Overstates legally permissible potencies (e.g., 30–40 mg/serving as retail “premium,” >100 mg/serving for “micro‑dosing kits” is contradictory and misleading)",
        "Fails to note adult‑use variation (5–10 mg/serving) and that medical programs may allow higher limits",
        "CBD guidance lacks regulatory context and can be misconstrued",
        "Includes extraneous formulation ceilings (5% w/w) that distract from regulatory potency limits and has an unfinished sentence"
      ],
      "feedback": "Refocus on regulatory potency caps: most adult‑use markets limit THC to 5–10 mg per serving and about 100 mg per package, with medical programs sometimes allowing higher limits. Correct the Canada note (10 mg per package) and avoid implying EU harmonization. Remove or clearly qualify claims about 30–40 mg or >100 mg per serving as these are typically non‑compliant in adult‑use retail. Add concise CBD regulatory considerations and ensure statements are jurisdiction‑specific or framed as general trends.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "edible",
        "potency",
        "thc",
        "cbd",
        "dosage",
        "milligram"
      ],
      "expectedAnswer": "**Drafting grading summary** I need to create a grading summary for the topic \"How potent can our edibles be?\" It's under the category of edibles-potency-formulation, and it includes some agents like CBD and its applications. The focus should be on potency regulations, noting THC limits per serving and per package, along with CBD considerations. While we don't have specific state-by-state details, I can summarize that adult-use states usually limit THC to 5-10 mg per serving and 100 mg per package. Medical states can have higher limits."
    },
    {
      "questionNum": 15,
      "question": "Can we do 100 or 200 mg packages?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "The short answer is **yes—most jurisdictions allow 100 mg and 200 mg package sizes**, but the feasibility depends on a few key factors:\n\n| Factor | What to check | Typical guidance |\n|--------|----------------|-------------------|\n| **State/Provincial regulation** | Look up the specific cannabis‑product rules for the market you’re selling in (e.g., California – adult‑use, Canada – Health Canada). | • California permits up to 100 mg THC per edible package (or 200 mg for certain “high‑dose” products with extra warnings). <br>• Canada allows up to **10 mg THC per serving** and **≤100 mg per package** for edibles; concentrates can be sold in 100 mg or 200 mg containers if labelled correctly. |\n| **Product type** | Edibles, tinctures, vape cartridges, concentrates, topicals, etc. | • Edibles: 10 mg per serving is the norm; a 100 mg package would contain 10 servings. <br>• Concentrates (e.g., vape cartridges, dabs): 100 mg or 200 mg of THC/CBD is common, but labeling must show total cannabinoid content and potency per gram/mL. |\n| **Labeling & packaging requirements** | Mandatory child‑proof, tamper‑evident, and specific label fields (total THC/CBD, serving size, warning statements, QR code, batch/lot number). | • California: “Contains 100 mg THC – Not for sale to minors” and a “High‑THC” warning for >100 mg. <br>• Canada: Standardized cannabis symbol, “THC 100 mg” or “THC 200 mg” plus “Do not exceed 10 mg per serving.” |\n| **Testing & potency verification** | Labs must certify the exact THC/CBD content for each batch. | Ensure your analytical results fall within ±10 % of the declared 100 mg/200 mg amount; many regulators require a “potency tolerance” of 10 % or less. |\n| **Market demand & pricing** | Consumer preferences vary; higher‑dose packages are often sold at a premium. | Conduct a quick market‑size analysis—if you’re targeting experienced users, 200 mg packs can be attractive; for casual users, 100 mg may be the sweet spot. |\n\n### Quick Checklist to Move Forward\n\n1. **Confirm jurisdiction** – Identify the state/province where the product will be sold.  \n2. **Review the specific packaging limits** – Verify the maximum allowed total THC/CBD per package for your product category.  \n3. **Finalize product formulation** – Ensure the batch can consistently hit 100 mg or 200 mg total potency with the required serving‑size breakdown.  \n4. **Secure lab testing** – Obtain a Certificate of Analysis (COA) that confirms the exact cannabinoid content.  \n5. **Design compliant packaging** – Include all required warnings, child‑proof features, QR code, and the exact “Total THC/CBD” figure.  \n6. **Run a pilot** – Produce a small run, test market response, and confirm that the product passes any post‑market inspections.  \n\n### Bottom‑Line Recommendations\n\n- **If you’re in the U.S.**: Most adult‑use states permit 100 mg edible packages and 100–200 mg concentrate containers, provided the label includes the proper “high‑dose” warnings.  \n- **If you’re in Canada**: Edibles are capped at 100 mg per package; concentrates can be sold in 100 mg or 200 mg containers, again with strict labeling.  \n- **If you’re in a different market** (e.g., Europe, Australia): Check the local cannabis authority’s packaging limits—some restrict edibles to 10 mg per serving with a 30 mg package cap.\n\n---\n\n**Next step:**\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1129 (129?1000) | Cost: $0.000000*",
      "duration": 21967,
      "grade": "F",
      "score": 54,
      "grading": {
        "accuracy": 7,
        "completeness": 13,
        "relevance": 16,
        "clarity_structure": 13,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly addresses the question with a jurisdiction-dependent approach",
        "Provides a clear structure with factors and a practical checklist",
        "Highlights key compliance themes (testing, child-resistant packaging, serving size norms)"
      ],
      "weaknesses": [
        "Incorrect claim that California permits 200 mg edible packages; CA caps edibles at 100 mg/package for both adult-use and medical",
        "Misstates Canada limits; standard edible cannabis is capped at 10 mg THC per package, not 100 mg",
        "Overgeneralizes that most jurisdictions allow 200 mg packages for edibles, which is not true in many adult-use markets",
        "Provides questionable labeling specifics (e.g., required phrases) and inaccurate cross-market guidance (EU/Australia)",
        "Omits key compliance elements from the expected answer: homogeneity/variance tolerances, universal cannabis symbol, allergen disclosures, nutrition facts, net weight, and clear medical vs adult-use distinctions",
        "Does not address CBD-only/hemp regulatory distinctions"
      ],
      "feedback": "While the answer is structured and offers a practical checklist, it contains significant regulatory inaccuracies (notably for California and Canada) and overgeneralizations about 200 mg edible packages. Refocus on accurate, jurisdiction-specific limits: most U.S. adult-use markets cap edibles at 10 mg/serving and 100 mg/package; 200 mg is typically restricted to certain medical categories or non-edible formats. Add required elements such as serving homogeneity and variance tolerances, universal symbol, allergen and nutrition labeling, batch ID and net weight, and clarify CBD-only/hemp rules.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "epa",
        "board",
        "standard",
        "test",
        "lab",
        "potency",
        "control",
        "batch"
      ],
      "expectedAnswer": "**Summarizing cannabis edibles potency** I need to create a concise summary for the question about whether we can do 100 or 200 mg packages of cannabis edibles. It seems odd that the context includes CBD effects, epilepsy dosing, and cannabis in cats, but doesn't directly address edibles potency. For the summary, I’ll outline that it often depends on jurisdiction. Many states cap THC per package, typically around 100 mg for adult-use edibles, whereas medical products might have higher limits. CBD-only products typically follow hemp regulations.**Listing key requirements** I need to include essential requirements for cannabis edibles like serving size, homogeneity, and variance. Testing protocols are important too, along with child-resistant packaging. I can't forget about the universal symbol for cannabis products, clear labeling warnings, and ingredient allergen info. Nutrition facts should be included if the product is edible, and also, I need to mention the batch ID and net weight. All these elements contribute to ensuring safety and compliance in the marketplace.**Summarizing cannabis edibles potency** I need to create a concise summary for the cannabis industry regarding whether 100 or 200 mg packages of edibles are permissible. The context I have involves CBD, its effects on epilepsy, and even cannabis for cats, but that’s not directly related to potency limits for edibles. I can outline that it really depends on jurisdiction, as many states set limits on THC per packag..."
    },
    {
      "questionNum": 16,
      "question": "Can we do more than 200 mg?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "I’m happy to help, but I need a bit more context to give you a safe, accurate answer. \n\n- **What product or substance are you referring to?** (e.g., a cannabis edible, tincture, vape cartridge, etc.)  \n- **What form is it in?** (mg per serving, per milliliter, etc.)  \n- **What’s your experience level or tolerance?** (first‑time user, occasional, regular)  \n- **Any health considerations?** (medications, conditions, age, pregnancy, etc.)\n\nOnce I know the specifics, I can let you know whether a dose above 200 mg is advisable, what the typical limits are, and what safety precautions to take.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 407 (166?241) | Cost: $0.000000*",
      "duration": 4467,
      "grade": "F",
      "score": 28,
      "grading": {
        "accuracy": 6,
        "completeness": 2,
        "relevance": 6,
        "clarity_structure": 12,
        "practical_value": 2,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, polite tone and organized structure",
        "Emphasizes safety and desire for context before advising"
      ],
      "weaknesses": [
        "Does not answer the core question about exceeding 200 mg",
        "Omits key regulatory details such as typical per-serving (10 mg) and per-package (100 mg) caps",
        "No jurisdiction-specific guidance (e.g., Michigan adult-use vs medical limits)",
        "Lacks discussion of medical vs adult-use differences or beverage exceptions",
        "Provides no actionable guidance or references",
        "Includes extraneous meta text that reduces professionalism"
      ],
      "feedback": "The response is clear but fails to address the question. Provide a concise summary of edibles THC limits, noting that most adult-use states cap at 10 mg per serving and 100 mg per package, with some medical markets allowing higher limits (e.g., around 200 mg in certain jurisdictions) and occasional higher allowances for specific formats like beverages. Include Michigan specifics (adult-use 10 mg/serving, 100 mg/package; higher caps may apply in medical) and advise checking current state regulations. Then, if needed, ask for user context.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "standard",
        "test",
        "lab",
        "edible",
        "gummy",
        "vape",
        "milligram",
        "thc",
        "cbd",
        "cannabinoid",
        "label",
        "delivery",
        "safety",
        "potency",
        "dosage"
      ],
      "expectedAnswer": "**Summarizing edibles potency limits** I need to summarize the expected answer to the question about whether we can exceed 200 mg in edibles. This involves the category of edibles, potency, and formulation. The context includes research on CBD for various uses, but it's not directly about edibles regulation. Many states in the US have different caps on THC, typically at 100 mg per package, but some allow higher limits for medical use or beverages. For instance, Michigan allows 200 mg for medical edibles.**Clarifying Michigan's THC limits** I need to confirm Michigan's regulations regarding THC limits in edibles. For adult-use cannabis, it seems they allow 10 mg per serving and a maximum of 100 mg per package. However, medical marijuana-infused products may go up to 200 mg per package. I'm not entirely sure about this, so I should double-check to get accurate information. It's important to have clarity on these details for any further discussions or decisions.**Summarizing cannabis potency regulations** I need to create a concise summary regarding the question about potential increases in cannabis edibles potency beyond 200 mg. The context covers dosage guidelines for CBD and its safety when used in formulations. Many US states have THC caps per package, typically at 100 mg, while some medical markets allow higher limits, going up to 500 mg or even 1000 mg. Regulations vary significantly, especially for beverages, so I'll clarify this in the summary.**Recalling Michigan mariju..."
    },
    {
      "questionNum": 17,
      "question": "Is there a per-piece requirement for max dosage?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "formulation",
      "agentMatch": true,
      "response": "**Short answer:** Yes – most jurisdictions that allow commercial cannabis edibles set a **maximum THC (or CBD) amount per individual serving/piece**. The exact limit depends on the country, state/province, and product category.\n\n---\n\n## 1. Typical Regulatory Bench‑marks (U.S. & Canada)\n\n| Jurisdiction | Max THC per **single serving/piece** | Max THC per **package** | Notes |\n|--------------|--------------------------------------|--------------------------|-------|\n| **Colorado** | 10 mg THC (or 10 mg CBD) | 100 mg THC total | “Serving” is defined by the manufacturer; must be clearly labeled. |\n| **Washington** | 10 mg THC per serving | 100 mg THC total | Same rule; “single dose” language used in labeling. |\n| **California** | 10 mg THC per serving | 100 mg THC total | Edible “serving size” must be declared; can be less than 10 mg. |\n| **Oregon** | 10 mg THC per serving | 100 mg THC total | “Single dose” terminology required on packaging. |\n| **Massachusetts** | 10 mg THC per serving | 100 mg THC total | Same as above. |\n| **Canada (federal)** | 10 mg THC per **single‑serve** edible | 30 g (or 30 ml) of product, max 30 mg THC per package for “single‑serve” items | A “single‑serve” product cannot exceed 10 mg per unit; a “multi‑serve” product can contain up to 100 mg total but must be clearly divided into ≤10 mg servings. |\n| **European Union (selected countries)** | Varies – many limit to **5–10 mg THC per unit** for food supplements | Often 20–30 mg per package | No unified EU rule; each member state sets its own limit. |\n\n> **Bottom line:** In the major legal markets the de‑facto standard is **10 mg THC (or CBD) per piece**. If you exceed that, the product must be marketed as “multi‑serve” and the total package limit (usually 100 mg) applies.\n\n---\n\n## 2. How to Design a “per‑piece” Formulation that Meets the Limit\n\n1. **Define the Target Dose**  \n   - Desired potency per piece (e.g., 5 mg, 7.5 mg, 10 mg).  \n   - Choose a dose that gives a comfortable margin below the legal ceiling (e.g., 8 mg to stay well under 10 mg).\n\n2. **Calculate Raw Material Requirements**  \n   \\[\n   \\text{Cannabinoid (mg)} = \\frac{\\text{Target dose (mg)}}{\\text{Extraction efficiency (\\%)}}\n   \\]\n   *Example:* Target = 8 mg THC, extraction yield = 70 % →  \n   \\[\n   \\frac{8}{0.70}=11.4\\text{ mg of raw THC‑rich material per piece}\n   \\]\n\n3. **Select an Homogeneous Carrier**  \n   - **Fat‑based matrices** (e.g., butter, MCT oil, chocolate) give the most uniform distribution.  \n   - **Water‑based gels** need emulsifiers (lecithin, polysorbate 80) to prevent “hot spots”.\n\n4. **Mixing Process**  \n   - Use a **planetary mixer** or **high‑shear homogenizer** to achieve <5 % coefficient of variation (CV) across a batch.  \n   - Validate uniformity by sampling at least 30 individual pieces and measuring THC via HPLC.\n\n5. **Quality‑Control Checks**  \n   - **Potency testing** on a per‑piece basis (or a statistically valid sub‑sample).  \n   - **Microbial & pesticide screens** per local regulations.  \n\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1203 (203?1000) | Cost: $0.000000*",
      "duration": 9915,
      "grade": "F",
      "score": 48,
      "grading": {
        "accuracy": 9,
        "completeness": 12,
        "relevance": 11,
        "clarity_structure": 12,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly acknowledges that most jurisdictions set per-serving (per-piece) maximum THC limits",
        "Identifies the common adult-use benchmark of ~10 mg THC per serving and ~100 mg per package in several U.S. states",
        "Clear, organized structure and inclusion of packaging context"
      ],
      "weaknesses": [
        "Incorrectly claims a 10 mg CBD per-serving limit in Colorado (CBD generally does not have a per-serving cap in these adult-use edible regs)",
        "Substantially incorrect Canadian limits (adult-use edibles are capped at 10 mg THC per package, not 30 mg per package for single-serve or 100 mg for multi-serve as stated)",
        "EU assertions are misleading; there is no harmonized EU standard allowing 5–10 mg THC per unit",
        "Misleading suggestion that exceeding per-serving limits is acceptable if marketed as multi-serve; most jurisdictions cap per-serving at 10 mg THC regardless, with requirements for scoring/demarkation if a piece contains multiple servings",
        "Omits key nuances such as medical program allowances, homogeneity/variance tolerances, and microdose norms (e.g., 2.5–5 mg pieces)",
        "Does not address hemp/CBD product THC constraints (e.g., 0.3% THC or ~1 mg THC per serving/product limits in some markets)",
        "Includes lengthy formulation/manufacturing guidance that is not requested and distracts from the regulatory question"
      ],
      "feedback": "Focus on a concise regulatory summary. Correct key inaccuracies: per-serving caps generally apply to THC (not CBD), Canada adult-use edibles are limited to 10 mg THC per package, and the EU does not have a unified 5–10 mg THC/unit allowance. Clarify that per-piece must not exceed the per-serving cap, or pieces must be clearly demarcated into ≤10 mg servings. Add brief notes on medical exceptions, homogeneity tolerances, microdose norms (2.5–5 mg), and hemp/CBD THC limits. Remove extraneous formulation details.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "must",
        "state",
        "federal",
        "fda",
        "standard",
        "testing",
        "test",
        "coa",
        "lab",
        "potency",
        "control",
        "batch",
        "sample"
      ],
      "expectedAnswer": "**Summarizing cannabis dosage regulations** I need to produce a concise summary regarding the cannabis industry question about per-piece dosage requirements for edibles. I see that my context about CBD effects and cannabinoids in cats isn't relevant here, but the user did mention needing state-specific info if available. While the RAG doesn't cover regulatory details, I know that many US and Canadian jurisdictions have general per-serving THC limits, commonly around 10 mg per serving for adult-use, and some medical states allow higher limits.**Explaining dosage specifics** I see that for cannabis edibles, some jurisdictions allow microdose pieces as low as 2.5 or 5 mg. Others may have requirements for dosage homogeneity and variance tolerances. For CBD-only products, they usually don’t have a per-piece THC requirement but instead mandate that THC content must be limited to either 0.3% or 1 mg THC per serving in hemp products. I want to make sure these details are clear and relevant for the user’s question!**Summarizing dosage regulations** I need to produce a concise summary regarding the cannabis industry's per-piece dosage requirements for edibles. The user wants to understand the max dosage regulations, including state-specific information if available. While the RAG context includes details on unrelated CBD uses, I’ll focus on general regulatory patterns in the U.S. and Canada, where many areas set limits of 10 mg THC per serving and 100 mg per package for adult use, with..."
    },
    {
      "questionNum": 18,
      "question": "What am I allowed to cut my vape cartridge APIs (distillate or decarbed resin) with that is safe and compliant?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "**Safe & compliant diluents for vape‑cartridge APIs (distillate or decarboxylated resin)**  \n\n| Diluents (cutting agents) | Why they’re considered safe | Typical use limits* | Compliance notes |\n|---------------------------|----------------------------|---------------------|-------------------|\n| **MCT (Medium‑Chain Triglyceride) oil – USP/GRAS‑grade** | Food‑grade, low viscosity, mixes well with cannabinoids, no known respiratory toxicity. | 10‑30 % of total cartridge volume (most states cap at 20 % for “diluted” products). | Allowed in most state‑licensed programs when the oil is **pharmaceutical‑grade** and the product is labeled as “MCT‑based”. |\n| **Propylene Glycol (PG) – USP‑grade** | FDA‑approved as a food additive and inhalation carrier; good solvent for terpenes and cannabinoids. | 5‑20 % (some jurisdictions limit PG to ≤10 % for vape products). | Must be **USP‑grade**; avoid formulations that exceed the state‑set PG/VG ratio limits. |\n| **Vegetable Glycerin (VG) – USP‑grade** | GRAS‑listed, provides a thicker vapor and reduces throat irritation. | 5‑20 % (often paired with PG to balance viscosity). | Same USP‑grade requirement; some states restrict total VG + PG to ≤30 % of the cartridge. |\n| **Terpenes (natural or isolated, USP‑grade)** | Enhance flavor/aroma, can act as mild diluents (≈5‑15 %). | ≤15 % of total volume (many states cap terpene content at 10‑15 %). | Must be **derived from cannabis or approved botanical sources** and be free of residual solvents. |\n| **Olive oil, sunflower oil, or other edible carrier oils** | Food‑grade, low toxicity, but higher viscosity; may affect device performance. | Generally ≤10 % if used; many regulators prefer MCT over other oils because of consistency. | Some states **explicitly prohibit** non‑MCT edible oils in vape cartridges; verify local rules. |\n| **Delta‑9 THC‑free “carrier” oils (e.g., hemp‑derived CBD oil)** | If the carrier is already a regulated cannabis extract, it can be blended as a “base”. | Depends on product potency limits; often treated as part of the total THC/CBD content. | Must be **fully tested** and labeled for its cannabinoid profile. |\n\n\\*Typical limits are drawn from a combination of **state cannabis‑regulatory guidances** (e.g., California Bureau of Cannabis Control, Massachusetts Cannabis Control Commission, Oregon Liquor & Cannabis Commission) and **industry best practices**. Always check the specific limits in your jurisdiction.\n\n---\n\n### Key Compliance Checklist\n\n1. **Use only **pharmaceutical‑grade (USP, GRAS)** ingredients.**  \n   - No vitamin E acetate, no industrial‑grade solvents, no non‑food‑grade propylene glycol or glycerin.\n\n2. **Document every lot** of diluent (certificate of analysis, supplier name, batch #).  \n   - Required for traceability during state inspections and for product recalls.\n\n3. **Label accurately**:  \n   - List each diluent by its INCI/common name (e.g., “MCT Oil”, “Propylene Glycol”, “Vegetable Glycerin”, “Terpenes”).  \n   - Include the **percentage** of each additive if the state mandates it.\n\n4. **Testing**:  \n   - Submit finished‑product samples for **potency, residual solvent, and microbial testing**.  \n   - Some states also require **aerosol toxicology** testing for inhalable products.\n\n5. **Device compatibility**:  \n   - Verify that the viscosity of your final blend matches the\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1178 (178?1000) | Cost: $0.000000*",
      "duration": 8553,
      "grade": "F",
      "score": 39,
      "grading": {
        "accuracy": 6,
        "completeness": 9,
        "relevance": 12,
        "clarity_structure": 9,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Addresses the topic of cutting agents for vape cartridges directly",
        "Includes a basic compliance checklist (documentation, labeling, testing)",
        "Calls out vitamin E acetate as prohibited",
        "Notes the need to verify terpene sourcing and provide COAs"
      ],
      "weaknesses": [
        "Recommends or normalizes unsafe/commonly prohibited diluents (e.g., olive oil; broadly endorses MCT, PG, VG) as safe/compliant",
        "Incorrectly implies USP/GRAS status equates to inhalation safety; fails to distinguish ingestion GRAS from inhalation toxicology",
        "Asserts questionable or false regulatory claims (e.g., “most states cap at 20%,” PG as an FDA-approved inhalation carrier, broad allowance of MCT/PG/VG)",
        "Omits key prohibitions and state-specific restrictions (e.g., bans/limits on PG/PEG/MCT; some jurisdictions allowing only cannabis-derived constituents/terpenes)",
        "Fails to mention PEG specifically, despite its relevance and common restrictions",
        "Testing section is incomplete (omits heavy metals and pesticides, commonly required; “aerosol toxicology” is overstated/rarely mandated)",
        "Contains an unfinished sentence and overgeneralized compliance statements"
      ],
      "feedback": "This answer contains significant safety and compliance inaccuracies. It presents MCT, PG, VG, and even olive oil as safe or commonly allowed, which conflicts with many state cannabis regulations and best practices for inhalation safety. USP/GRAS status does not confer inhalation safety, and several jurisdictions restrict or ban non-cannabis diluents, allowing only cannabis-derived terpenes within tight limits. The piece also omits PEG (often restricted), overstates uniform “percentage caps,” and lacks key testing requirements like heavy metals and pesticides. Revise to: (1) emphasize that many states permit only cannabis-derived terpenes (and explicitly ban vitamin E acetate, PEG, PG, VG, MCT, and other oils) in inhalables; (2) highlight that GRAS-for-ingestion is not inhalation-safe; (3) include jurisdiction-specific checks; (4) ensure full testing (potency, residual solvents, pesticides, heavy metals) and hardware compatibility; and (5) avoid recommending edible oils for cartridges.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "commission",
        "sop",
        "standard",
        "record",
        "test",
        "coa",
        "certificate",
        "analysis"
      ],
      "expectedAnswer": "**Summarizing vape cartridge compliance** I need to summarize the expected answer to the cannabis industry question about safe and compliant cutting agents for vape cartridges. The relevant knowledge base includes general cannabis compliance and formulation ingredient safety. There are restrictions on cutting agents, such as no vitamin E acetate and limitations on PG, PEG, or MCT in some states. We should also highlight that only cannabis-derived constituents may be allowed, with testing for heavy metals, residual solvents, and pesticides needing to be addressed.I'm considering the importance of temperature stability and viscosity in vape formulations while avoiding unknown diluents. It seems using food-grade terpenes or those recognized as GRAS (Generally Recognized as Safe) by FEMA might be an option. However, I've realized that just because something is GRAS for oral consumption doesn't guarantee inhalation safety. It's crucial to ensure any ingredients used are truly safe for inhalation. This aspect needs careful attention to prioritize user safety!**Evaluating safety and stability** I’m thinking about temperature stability and viscosity while avoiding unknown diluents. Should I consider food-grade terpenes that are GRAS (Generally Recognized as Safe) by FEMA? But I realize that inhalation safety can’t be guaranteed by GRAS, as it primarily applies to oral consumption. So, I need to be cautious about this choice. I’ll weigh the importance of both stability and safety in m..."
    },
    {
      "questionNum": 19,
      "question": "What are considered banned substances when formulating various cannabis products?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "### Quick‑Reference: Substances Typically **Banned** (or strictly limited) in Cannabis‑Product Formulations  \n\n| Category | Why it’s prohibited or limited | Common examples that are **banned** (or have very low allowable limits) |\n|----------|--------------------------------|-----------------------------------------------------------------------|\n| **Solvents & Extraction Media** | Residual solvents can be toxic, cause irritation, or leave unwanted flavor/odor. | • **Butane, Propane, Pentane, Hexane, Isobutane** – any residual > 500 ppm (EPA/Health Canada limits) <br>• **Petroleum‑based solvents** (e.g., mineral oil) <br>• **Carbon tetrachloride, chloroform** – outright prohibited |\n| **Carrier Oils & Lipids for Inhalation** | Linked to lung injury (e.g., EVALI). | • **Vitamin E acetate** (banned in vape liquids by FDA) <br>• **Medium‑chain triglyceride (MCT) oil** – allowed only in oral/topical products, not inhalation |\n| **Flavoring & Additive Chemicals** | Some generate toxic degradation products when heated; others are allergens. | • **Diacetyl, 2,3‑pentanedione, acetyl propionyl** – banned in inhalable products (FDA) <br>• **Benzaldehyde, cinnamaldehyde** – limited concentrations in vape liquids (generally < 0.1 % w/w) <br>• **Artificial sweeteners** (e.g., saccharin) – not permitted in inhalable products |\n| **Synthetic Cannabinoids** | Unapproved, high‑potency, unpredictable pharmacology. | • Any **JWH‑**, **CP‑**, **UR‑**, or other designer cannabinoid not listed on the Schedule I/II (US) or Schedule IV (Canada). |\n| **Pesticides & Agro‑chemicals** | Residues can exceed safety limits and cause chronic toxicity. | • **Organophosphates** (e.g., chlorpyrifos) <br>• **Carbamates** (e.g., carbaryl) <br>• **Pyrethroids** (e.g., permethrin) <br>• **Neonicotinoids** (e.g., imidacloprid) <br>• **Herbicides** such as glyphosate, paraquat, glufosinate <br>All must meet the *maximum residue limits* (MRLs) set by the jurisdiction (often < 0.5 ppm for many pesticides). |\n| **Heavy Metals & Metalloids** | Accumulate in the body; neuro‑toxic at low levels. | • **Lead (Pb)**, **Cadmium (Cd)**, **Arsenic (As)**, **Mercury (Hg)** – typically limited to ≤ 0.1 ppm (US FDA) or ≤ 0.5 ppm (EU) in the final product. |\n| **Mycotoxins & Microbial Contaminants** | Can cause acute or chronic health effects. | • **Aflatoxin B1**, **Ochratoxin A**, **Fumonisins**, **Patulin** – usually required to be **non‑detectable** (< 0.2 ppb for aflatoxin B1). <br>• **Total aerobic count**, **yeast & mold** – must meet pharmacopeial limits (e.g., < 10⁴ CFU\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1130 (130?1000) | Cost: $0.000000*",
      "duration": 13666,
      "grade": "D",
      "score": 61,
      "grading": {
        "accuracy": 15,
        "completeness": 14,
        "relevance": 16,
        "clarity_structure": 10,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Organizes banned items by category (solvents, inhalation lipids, flavor chemicals, synthetic cannabinoids, pesticides, heavy metals, microbes)",
        "Correctly flags vitamin E acetate as unsafe for inhalable products",
        "Highlights core contaminant classes (pesticides, heavy metals, mycotoxins, residual solvents) that are commonly regulated via action limits"
      ],
      "weaknesses": [
        "Misattributes regulatory authority (e.g., states typically ban vitamin E acetate in cannabis vapes; FDA has not universally banned it in all vape products)",
        "Provides questionable or incorrect numeric limits for residual solvents, heavy metals, and mycotoxins that do not match common state cannabis action levels",
        "Omits key banned ingredients such as nicotine, caffeine, and alcohol (and the prohibition on co-formulating alcohol with THC in most states)",
        "Does not address child-appealing additives/claims and certain flavor restrictions common in state cannabis rules",
        "Lacks state-specific nuances and references (e.g., CA, CO, MA, MI action limits and ingredient prohibitions)",
        "Overgeneralizes (e.g., MCT oil “not allowed” in inhalation is not a universal rule across all jurisdictions)",
        "Truncated/incomplete table and missing vaping excipient restrictions often cited (e.g., PEG/PG/triacetin/sugars in inhalables)"
      ],
      "feedback": "The answer is directionally helpful but includes several inaccuracies and critical omissions. Avoid attributing blanket bans to FDA for cannabis formulations; in the U.S., state cannabis regulators set most ingredient prohibitions and action limits. Replace generic or incorrect numeric limits with jurisdiction-specific action levels (e.g., CA BCC/DPH or CO MED tables for residual solvents, heavy metals, and mycotoxins). Add clearly prohibited ingredients that many states list: nicotine, caffeine, alcohol (and no co-formulation of alcohol with THC), prescription drugs, and certain cutting agents in vapes (vitamin E acetate and often PEG/PG/triacetin/sugars). Note child-appealing flavors/imagery restrictions and product-type distinctions (oral vs inhalation vs topical). Provide examples by state to improve practical compliance guidance.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "state",
        "federal",
        "fda",
        "board",
        "standard",
        "log",
        "lab",
        "contaminant",
        "pesticide",
        "microbial",
        "mycotoxin",
        "heavy metal",
        "control",
        "edible"
      ],
      "expectedAnswer": "**Summarizing banned substances** I need to create a summary about banned substances in cannabis product formulation, like what agents are restricted for compliance. I should emphasize key requirements and regulations, including specifics for various US states. While I have some context about CBD and its effects, I need to stick to general cannabis regulations. Common banned substances include adulterants, synthetic cannabinoids, vitamin E acetate for inhalables, and potentially cutting agents like PEG. Some flavorings, especially child-appealing aspects, are also restricted.**Clarifying banned ingredients** I need to outline certain banned substances in cannabis product formulation, particularly those that exceed action thresholds. This includes harmful pesticides, mycotoxins, heavy metals, and residual solvents above acceptable limits. Additionally, some ingredients are strictly prohibited, such as nicotine, caffeine, and alcohol in formulations, except for specific beverage categories. However, it's important to note that THC-infused drinks typically cannot include alcohol. So, I’ll specify these key points clearly.**Summarizing banned substances in cannabis products** I need to create a summary about banned substances in cannabis product formulation, specifically focusing on compliance requirements. It's essential to include key regulatory details, particularly U.S. state specifics. In general, many states prohibit adulterants, synthetic cannabinoids, and products like vi..."
    },
    {
      "questionNum": 20,
      "question": "Can I use hemp-based cannabinoids like CBD or CBG (or others) in production of my cannabis products?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "formulation",
      "agentMatch": true,
      "response": "## Short answer  \nYes – you can formulate products with hemp‑derived cannabinoids (CBD, CBG, CBC, Δ⁸‑THC, etc.) **provided you stay within the legal limits for Δ⁹‑THC and meet any product‑specific regulations in the jurisdiction where you’ll sell the product**.  \n\nBelow is a practical roadmap that covers the key regulatory, quality‑control, and formulation considerations you’ll need to address before you start production.\n\n---\n\n## 1. Regulatory landscape (U.S. focus – adapt to your market)\n\n| Aspect | Hemp‑derived cannabinoids | Marijuana‑derived cannabinoids |\n|--------|---------------------------|--------------------------------|\n| **Legal source** | Must be extracted from *Cannabis sativa* plants containing ≤0.3 % Δ⁹‑THC (dry weight) as defined by the 2018 Farm Bill. | Requires a state‑issued cannabis license (medical, adult‑use, or industrial). |\n| **Δ⁹‑THC limit in final product** | ≤0.3 % Δ⁹‑THC by dry weight (federal) *and* often ≤0.05 % Δ⁹‑THC in the finished product (state‑specific). | No federal limit; state limits apply (often 10 % THC for edibles, 0.3 % for topicals, etc.). |\n| **FDA/USDA** | CBD is **not** approved as a food additive or dietary supplement; any health claim triggers FDA enforcement. Hemp‑derived products may be sold as cosmetics, topical, or “non‑intoxicating” items, but must avoid therapeutic claims. | Same FDA rules, but many states allow “medical” claims under their own licensing schemes. |\n| **Labeling** | Must list total cannabinoids, Δ⁹‑THC content, and any other cannabinoids present. No “potency” claims that imply a drug effect. | Must comply with state‑specific packaging/labeling rules (e.g., potency, batch number, warnings). |\n| **Testing** | COA required for potency, residual solvents, pesticides, heavy metals, microbial. Must be performed by a **state‑approved** lab if you sell in a regulated market. | Same, often with additional state‑mandated tests (e.g., mycotoxins, myrcene). |\n\n**Key take‑aways**\n\n* **If you are selling nationwide (e‑commerce) or in a non‑licensed market, stay under the 0.3 % Δ⁹‑THC threshold and avoid any “medical” language.**  \n* **If you are selling in a state‑regulated adult‑use market, you will need a cannabis license even for hemp‑derived cannabinoids, because the state treats all cannabinoids as “controlled” under its program.**  \n* **International markets**: EU (≤0.2 % Δ⁹‑THC), Canada (requires a cannabis licence for any product containing cannabinoids), Australia (requires a licence for CBD >150 mg/day). Always check the local threshold.\n\n---\n\n## 2. Sourcing & Quality Assurance\n\n1. **Supplier qualification**  \n   * Verify that the grower cultivates hemp under a USDA‑approved program (or equivalent).  \n   * Request a **Certificate of Analysis (COA)** for each batch covering:  \n     - Total cannabinoids (CBD, CBG, CBC, Δ⁸‑THC, Δ⁹‑THC, etc.)  \n     - Potency (mg/g)  \n     - Residual solvents (if extracted\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1182 (182?1000) | Cost: $0.000000*",
      "duration": 13012,
      "grade": "B",
      "score": 83.33333333333333,
      "grading": {
        "length": "Pass",
        "keywords": "11/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "3/5 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "must",
        "state",
        "federal",
        "fda",
        "sop",
        "procedure",
        "standard",
        "operating",
        "testing",
        "test",
        "coa",
        "certificate",
        "analysis"
      ],
      "expectedAnswer": "**Analyzing cannabinoid compliance** I need to create a grading summary addressing whether hemp-based cannabinoids like CBD or CBG can be used in cannabis product formulation. This is particularly relevant in the context of compliance and regulations, as many states have restrictions on “hemp-derived cannabinoids” in the marijuana market. I'll reference insights from three PubMed articles related to CBD and its implications. Additionally, I'll ensure to cover vital compliance pointers and address issues like “Total THC” calculations and synthetic conversion prohibitions to provide thorough guidance.**Clarifying federal versus state regulations** I should note that federal law, specifically the 2018 Farm Bill, defines hemp as cannabis containing less than 0.3% delta-9 THC. However, state cannabis programs frequently have stricter requirements, insisting that all cannabinoids must come from marijuana plants grown within regulated systems. This distinction is crucial for anyone looking to navigate the compliance landscape surrounding the use of hemp-derived cannabinoids in cannabis products. It's an important aspect to clarify for the user’s understanding.**Producing a grading summary** I need to create a grading summary for a question about using hemp-based cannabinoids like CBD or CBG in cannabis product production. I’ve got context from three PubMed articles, which is useful. The main focus is on compliance and regulatory aspects, which is very relevant currently due to restr..."
    }
  ],
  "status": "In Progress: 20/438 questions completed"
}